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ABSTRACT
RICHARD CHASEN SPERO: Small Particle Transport in Fibrin Gels
and
High Throughput Clot Characterization.
(Under the direction of Richard Superfine.)
The formation, function, and lysis of blood clots is largely governed by the trans-
port of nano- and micro-scale particles. Yet there is not fully established physics that
relates clot structure to transport phenomena such as fluid permeation and particle
diffusion. This dissertation explores small particle transport in fibrin. I report on
the size-dependence of particle mobility in fibrin, and discuss the implications of these
results for fibrinolytic drug design. I measure the relationship between fibrin permeabil-
ity and diffusion of 0.2–2.8 micron particles in fibrin gels, then determine the time and
length scales at which small particle diffusion is directly related to bulk gel permeabil-
ity. This result implies that one could develop a high throughput clot characterization
assay that provides more detail than turbidity, the predominant high throughput mea-
surement. I also present my work designing and developing systems to perform these
and other experiments in high throughput, which include novel technologies for optical
microscopy and magnetic force application.
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The formation, function, and lysis of blood clots is largely governed by the trans-
port of nano- and micro-scale particles. A physiological clot’s environment includes
blood, pathogens, cells, and drugs, which move through a fibrin scaffolding by various
mechanisms, including diffusion, advection, and active motility. The nature of clot
formation and lysis is a product of clot structure, fluid permeation, and particle trans-
port. Yet the physics relating these transport phenomena are not well understood. It is
not known, for example, what physical theory governs the diffusion of a small particle
through a clot, nor how that diffusion might be related to the bulk permeability of the
material. This dissertation will address these issues by determining the timescale- and
size-dependence of micro- and nano-particle diffusion in clots.
This work also has a context in soft matter physics. A wide range of scientists and
engineers studying everything from biological tissues to novel materials to gas filters
are concerned simultaneously with fluid permeation and particle transport through a
medium. This dissertation evaluates when permeation and particle diffusion are quan-
titatively related. I show that the timescale of the diffusion measurement is critical in
establishing this relationship, and thereby explain why prior work attempting to verify
the effective medium theory showed poor agreement with experiment. Validating the
effective medium theory establishes fibrin as a useful model material for studying par-
ticle diffusion over specific time- and length-scale regimes that are difficult to measure
in other materials.
Like most of biology, coagulation is a phenomenon of many input parameters, in-
cluding fibrinogen and thrombin concentration, calcium concentration, ionic strength,
pH, crowding agent concentrations, and genotype. With the advent of siRNA libraries,
one can imagine triggering clotting over a cell culture substrate, systematically knocking
down each of the more than 21,000 human genes to see whether clot structure above the
substrate is affected. Such an experiment would provide an unprecedented panorama
of the genes involved in thrombin generation. Unfortunately, assays that provide de-
tailed characterization of clots are typically low-throughput and labor-intensive. The
techniques of this dissertation promise to provide high throughput characterization of
clot structure, fluid permeation, and particle transport. I report on high throughput
instrumentation that I have designed and developed to enable my experiments. These
systems include an automated microscope built with components that may be tiled up
to 12 times below a conventional microplate, and a multiforce high throughput system
(MHTS) for force application in biophysical experiments. In this dissertation I report
on the design and qualification of these technologies.
This high throughput technology has applications that range far beyond clot char-
2
acterization. High throughput screening is increasingly critical in cell microscopy, but
existing systems suffer from slow 3D imaging, low-bandwidth in time-lapse experiments,
and incompatibility with force application or other mechanical measurements. The high
throughput technology I present in this dissertation addresses these issues.
1.1 Coagulation and Transport
Fibrin is the polymer scaffolding of a blood clot (Weisel, 2005). Damage to the
vascular endothelium1 reveals tissue factor, which triggers a cascade of reactions culmi-
nating in the conversion of prothrombin to thrombin. Thrombin activates fibrinogen, a
340kDa glycoprotein that is always present in healthy blood. An activated fibrinogen
molecule is called a fibrin monomer, which in sufficient concentration self-assembles
into a fibrous gel. Physiologically, fibrin gels nucleate from activated platelets or the
endothelium, ultimately sealing vascular breaches and restoring haemostasis. Clots are
broken down when tissue Plasminogen activator (tPA) converts plasminogen—another
protein endemic to blood—to plasmin, the factor that begins fibrinolysis (fibrin diges-
tion) and therefore limits clot lifetime within the vasculature.
When it functions properly, therefore, clotting is essential to health. Yet because
pathological clotting is the central risk of cardiovascular disease, it is also the top
contributor to the global burden of disease (WHO, 2004), whether through an occlusive
thrombus2 triggering myocardial infarction3, or a deep vein thrombus that dislodges
1vascular endothelium: the cells of the blood vessel wall
2thrombus: clot formation within the vasculature
3mycardial infarction: heart attack
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and results in pulmonary embolism4. These conditions arise from unwanted clotting;
failure to clot is similarly dangerous, as in hemophilia (Rodriguez-Merchan et al., 2000).
One might separate the requirements for clotting—both hemostatic (good) and
pathological (bad)—into the biochemical and the physical. The biochemical require-
ment is simply that to achieve coagulation there must be thrombin to activate fib-
rinogen, and that for lysis there must be plasmin to cleave fibrin. Hemophilia is an
example of a clotting pathology that is biochemical: this genetic disorder results in low
expression of Factors VIII or IX, both of which are involved in thrombin generation.
The physical requirement is that the factors must be at the sample location for suffi-
cient time to allow the reactions to occur. For example, thrombin is created when freely
circulating prothrombin is activated, near cells or platelets, by a complex of factors Va
and Xa. To achieve clotting, therefore, fibrinogen must come to these locations, or
thrombin must move away from them. Not surprisingly, then, the geometry of throm-
bin generation has an impact on gel structure (Wolberg and Campbell, 2008). Similarly,
to achieve clot lysis, plasminogen must encounter tPA to become plasmin, and must
then destroy the clot from the outside in, or travel into it; hence, the ability of a clot to
allow transport has an effect on the time required to dismantle it (Veklich et al., 1998).
Heart disease has been correlated to tight and rigid clots (Fatah et al., 1996), so clot
geometry is intimately tied with the difficulty in treating patients suffering myocardial
infarction due to thrombosis.
The physics of clotting includes kinetic considerations. The faster blood flows,
4pulmonary embolism: a thrombus that breaks free from a vessel wall and lodges in the lung
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the less conducive the environment is to clotting. This is demonstrated at formation,
where poor circulation is a risk factor for deep vein thrombosis, and at lysis, where
forced perfusion is a common (and painful) treatment (Wicky, 2009). This treatment is
used because increasing gel perfusion accelerates clot destruction (Diamond and Anand,
1993).
The coincidence of clotting agents and the time that they have to interact are deter-
mined by transport of blood and the biochemical factors therein. Transport is therefore
a key issue in clotting pathology and treatment, including transport of coagulation fac-
tors, which must be present only in the locations where clotting is desired, and also
transport of blood itself, which must stay contained, yet circulate freely, within the
vasculature.
1.1.1 Studying clot transport
Clot transport in vivo is the product of five (often simultaneous) phenomena: dif-
fusion, advection, steric hinderance, hydrodynamics, and chemical interaction. All
objects in solution are subject to thermal diffusion, the random motion of particles due
to the non-zero net impulse of many random collisions with solvent molecules. Because
blood is pumped by the heart, objects in clots also experience advection, the transport
of a particle being carried by local solvent flow. The presence of solid barriers, including
the endothelium and the fibrin mesh, hinder objects’ transport by steric interaction,
the physical exclusion of a particle from space filled with other solid matter. These
solid barriers place boundary conditions on the solvent, so objects may experience an
5
altered hydrodynamic environment. Finally, fibrin is not chemically inert, so objects
stick to the clot scaffolding, suppressing their transport. With enzymes that affect
clot structure—namely thrombin and plasmin—chemical interaction feeds back into
the other transport mechanisms, as formation or destruction of the clot may affect the
conditions that determine diffusion, flow, or collisions.
These are the relevant mechanisms determining transport in clots. However, they
are not always the properties measured in studies of clot formation, function, and lysis.
Today, research of transport in clots typically involves at least one measurement among
permeation, imaging, or turbidity. Permeability is an explicit metric of hemostasis and
of fluid transport through the clot, and it has been correlated with diabetes (Dunn et al.,
2005) and heart disease (Fatah et al., 1992; Fatah et al., 1996). Permeability is blind
to microscopic details of particle transport, and is a low-throughput technique. Yet the
physiological relevance of the measurement cannot be ignored, so a permeability assay
that could reveal microscopic aspects of clot structure and scale to high throughput
format would be an important contribution to the field. I show in Chapter 3 that at
the appropriate time and length scales, nanoparticle diffusion can serve as this assay.
Imaging—primarily confocal and electron microscopy—has been used to measure
clots’ formation and microscopic structure (Blomba¨ck et al., 1994; Blomba¨ck et al.,
1989). Microscopy makes no explicit transport measurement, although recent efforts
have extracted clot porosity from clot images (Collet et al., 2003; Mickel et al., 2008),
which in turn may help predict transport. The more commonly calculated parameters
(branchpoint density, fiber length, and diameter) are notoriously labor-intensive to
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extract, and imaging techniques have inherent errors in measuring fiber size. This begs
the question of whether a non-imaging measurement could provide implicit structural
information about the gel. Based on theories that I introduce in Chapter 2, I show in
Chapter 3 that a combination of permeability and diffusion measurements can provide
quantitative insight into the structure of fibrous gels.
Turbidity, a measurement of bulk optical transmission, is of particular interest be-
cause it is inexpensive, can be performed in high throughput (Wolberg et al., 2002),
and is used as an indirect measurement of fiber diameter and fiber protein density (Carr
and Hermans, 1978). Turbidity probes bulk-averaged structure of the clot, so one might
imagine that it would be sufficient to predict bulk-averaged resistance to fluid flow (per-
meability). Indeed, experts in the field have developed a rich intuition for interpreting
turbidity curves. However, as I explain in Section 2.3.4, turbidity cannot be used to
predict gel permeability.
Of these three methods, none offers direct measurement of particle transport in
clots. Given the relevance of particle transport to clot formation and lysis, such an
assay would be of scientific, and potentially clinical, value. A particle transport assay’s
usefulness would be determined by (1) its sensitivity to relevant clot properties, (2) a
known relationship to the other commonly studied parameters of permeability, imaging,
and turbidity, and (3) instrumentation that is well qualified to be deployed and used
outside of our research group. In this work, I present a diffusion-based clot assay and
address all three of these considerations.
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1.2 Scope of this Research
The prior work discussed above has highlighted conditions where diffusion is a key
phenomenon in clot formation and lysis, including the impact of thrombin concentration
gradients on clot structure and the speed of clot lysis on permeant velocity. But the
actual behavior of diffusing particles in clots is not well established, beyond the fact
that particle surface chemistry affects mobility (Valentine et al., 2004) and that fiber
stiffness can be measured by diffusion of stuck particles (Jahnel et al., 2008). It has
not been established how a particle’s diffusion scales with its size.
More broadly, the work reviewed in Section 1.1 has highlighted the involvement of
specific transport phenomena, but it has not explored their governing physics. Without
identifying the relevant theory, predictive models of clot formation, haemostasis, and
lysis will remain elusive. These models would help clarify clot biology, and could
potentially assist in designing drugs, stents, and other biomedical devices.
From a physical perspective, fibrin also provides a model system for understanding
physical properties of highly elastic, low volume fraction, fibrous media. Specifically,
it is unknown whether the bulk properties of fibrin gel relate to micro-scale properties,
including whether the behavior of micron-sized probes carries information about the
bulk viscoelasticity of the gel, about its bulk permeability, or about its structure.
This dissertation addresses these questions. In Chapter 3 I report on experiments
with passively diffusing nano-particles. Particle diffusion in fibrin is indeed dependent
on particle size, and the timescale over which the particle diffuses. I focus on the
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hundreds-of-nm regime, using 500 nm particles for many experiments, and ranging in
size from 200 nm to 2.8 µm. The 500 nm particles are half to a tenth the size of
platelets or cells that might perfuse a clot; they are ten to 100 times the size of ambient
proteins or drugs. Comparing directly with these physiological agents is not necessarily
fruitful—platelets, cells, enzymes, and drugs can all interact biochemically with fibrin.
However, chemically inert probes at this length scale are in a physically intriguing
regime: they are small enough to diffuse through the fibrin matrix, but big enough
that they seem likely to collide with it. I show the sensitivity of particle transport to
particle size, and based on these results I propose a drug design to maximize lysis of
occlusive thrombi while minimizing the risk of hemorrhage.
In Chapter 3 I also demonstrate that at short timescales (τ < 1 s), and for small
(d ≤ 500 nm), chemically inert particles, diffusion and permeability are intimately
related, and that one can actually predict the other through the effective medium
theory. I explain that therefore hydrodynamic, rather than steric, effects dominate
diffusion at the micro-scale. Larger particles are more likely to become lodged in the
gel, and 1 µm particles are found to always be stuck. At longer timescales, I report on
evidence that steric effects may be affecting particle diffusion.
Chapter 3 answers questions about the nature of stuck particles. In Chapter 4
I show that micron-scale particles in fibrin—which do not freely diffusion—are not
strongly adhered to the gel. By applying forces on the order of those found in arterial
flow, micron-scale particles will move long distances (> 100 µm), suggesting that such
particles may be useful as drug delivery vectors for fibrinolytic treatments. In addition,
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I show that for particles at least 2.8 µm and smaller, driven micro-rheology measures a
local mechanical property of the clot, rather than the bulk viscoelastic properties of the
gel, and that it can measure time-dependent stiffening of fibrin during clot formation.
In addition to my scientific work focused on fibrin and other fibrous gels, I have
helped to design, build, and qualify systems for high throughput microscopy, manipu-
lation, and rheology that are designed to address the needs of these and other experi-
ments. They are core technologies for a microrheology and cell screening system that is
presently under development. These systems and my contributions to their realization
are the subject of Chapter 5.
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Chapter2
Transport in Fibrin: Theory
When particles move in clots, what phenomena are at play? The physical environ-
ment for diffusing particles, and the fluidic environment during permeation, are not
well understood in clots. In this Chapter, I begin with the impact a gel is expected
to have on a diffusing particle and on a permeating fluid. The presence of a gel will
impose boundary conditions on the fluid, as well as on the particle motion. I determine
the relevant length and timescales for these effects.
In the remainder of this Chapter I explore the relationship of gel structure to trans-
port. Imaging has been used to extract gel structure, including fiber density (Campbell
et al., 2008), branchpoint density (Ryan et al., 1999), and gel porosity (Mickel et al.,
2008). However, this information has not been used to test the quantitative theories
that use these structural parameters to predict particle diffusion or fluid permeation.
Therefore, I will spend some pages looking in detail at the theoretical relationships
among structure, permeation, and particle transport. The goal of this Chapter is to
clarify what theories exist, which might be relevant in fibrin modeling, and how using
one theory might help validate or invalidate the applicability of others.
2.1 Expectations for particle motion in fibrin
2.1.1 Single Particle Diffusion
In classical physics, diffusion was understood through the lens of Fick’s laws, which
described the phenomenon in terms of concentration gradients (Cussler, 1997). It was
Einstein who provided the physical explanation for single particle diffusion (Einstein,
1905), often called Brownian motion. This explanation is captured in the Stokes-









where kB and T are Boltzmann’s constant and absolute temperature, respectively. D is
the diffusion coefficient of the material. For aspherical solutes, the denominator f may
be replaced by the Stokes drag formula (Happel and Brenner, 1983) for that geometry.
Einstein noted that D determines the time-averaged position of the particle
〈r2〉 = 4Dτ, (2.2)
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where 〈r2〉 is mean squared displacement, and τ is the time between position mea-
surements during which the particle diffuses. Einstein also explained that the D of
Equation 2.1 can explain the bulk diffusion of Fick’s Laws, provided that material is
homogeneous and invariant in time.
While for many natural and engineered systems homogeneity and stasis are ap-
propriate assumptions, for biological systems it is rarely appropriate to apply either.
First, polymers are typically viscoelastic—namely, under stress they exhibit frequency-
dependent frictional loss and elastic energy storage (Ferry, 1980). Polymer solutions are
spatially heterogeneous on certain length scales, and the interaction of polymer chains
with suspended particles depends on the size of the particles, the physical parameters
of the chain (chain length and flexibility), and the nature of the solution (the quality of
the solvent and the concentration of polymer) (Rubinstein and Colby, 2003). Biological
materials can be even more heterogeneous; for example, mucus comprises pathogens
and particulates suspended amidst a solution of polydisperse mucins (Thornton et al.,
2008). Fibrin is viscoelastic (Roberts et al., 1974); it also exhibits temporal hetero-
geneity during clot formation and lysis, and spatial heterogeneity on length scales at
or below the mesh size of the gel.
Measurements of single-particle diffusion, made possible by advances in microscopy
and single-particle tracking, reveal some of these complexities. In homogenous but
viscoelastic materials, it has been observed that diffusion of particles is suppressed on
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certain timescales such that
〈r2〉 ∝ τα (2.3)
where 0 < α < 1 (Wong et al., 2004). The powerlaw α may not be constant over
all timescales. However, for any range of τ over which α = 1, the average motion is
Brownian. (There are instances where the average motion is Brownian but the step
size distribution is non-gaussian (Wang et al., 2009); in this dissertation, I have seen
no evidence of such an effect.) In such cases it is useful to generalize Equation 2.2 by
taking D → Deff , with the “effective” subscript capturing the concept that the material
appears purely viscous, although no aspect of the particle-polymer-solvent system can
be said truly to have a viscosity corresponding to Deff .
For homogeneous media, variations in α can be explained as the result of frequency-
dependent elastic storage and viscous losses. Mason and Weitz have explained that the
complex modulus G∗(ω) of a bulk material may therefore be extracted from r(t) (Mason
and Weitz, 1995). This approach has since become a key technique in the larger field
of microrheology (Waigh, 2005; Cicuta and Donald, 2007; Kimura, 2009).
Fibrin, however, is not homogeneous on the micron length scale. Therefore, much
of microrheology is not expected to be relevant in this material. To develop a sound
model of transport, we need to be clear about valid assumptions one can make about
the gel.
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2.1.2 Assumptions for fibrin modeling
The coagulation community has a language for describing fibrin gel phenotypes.
Clots are often described as coarse (few thick fibers, low volume fraction) or fine (many
thin fibers, high volume fraction), but the terms are not always clearly defined. I have
summarized the definition of these qualitative terms in Figure 2.1.
Figure 2.1: Clots at a given fibrinogen concentration have a range of phenotypes,
from “fine” to “coarse,” depending on the polymerization conditions. This car-
toon defines these terms relative to the physical parameters of fiber diameter
(df) and volume fraction (φ), which are useful in quantitatively describing clot
structure. For a clot of fixed fibrinogen concentration, a clot becomes finer when
the same fibrin is distributed over more fibers, increasing fiber number density
n but decreasing df . To first order, volume fraction φ should remain the same,
but there are indications that thicker fibers pack fibrinogen more densely than
thin fibers (Guthold et al., 2007), meaning volume fraction would also increase
as clots become finer. Clot coarseness is typically inversely proportional to poly-
merization rate—for example, high thrombin concentration leads to finer clots.
Clot density increases with rising fibrinogen concentration.
Platelet-poor plasma (PPP) and purified fibrin clots are fibrous gels. The material is
heterogenous on the nanometer-to-micron length scale, as is clear from the microscopy
of Figure 2.2, which shows representative images of all the clot types studied in the
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present work. In the absence of external stress, the fiber segments are straight and can
be considered rigid rods, as recent work has identified the persistence length lp of fibrin















Normal PPP Hemophilic PPP Treated PPP
Figure 2.2: Confocal microscopy of the clot types studied in this work. As has
been well established in prior work, clot coarseness decreases with thrombin con-
centration (first row) and fibrinogen concentration (middle row). Platelet-poor
plasma (PPP) clot structure also varies with pathology. In this case, hemophilic
clots are coarser than normal clots, and rFVII can restore some of the lost density
(last row). Scale bar is 20 µm
On the second to week-long timescales, the gel may be considered invariant in
time. After gel formation, and in the absence of any fibrinolytic agent, fibrin structure
apparently does not change unless dehydration or contaminating bacteria damage the
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scaffolding. On minute and second timescales, the gel does not move under confocal
microscopy. From day to day, confocal images of the gel do not change in any discernible
way.
In fibrin networks there is little space that actually contains fibrin, a quality cap-
tured in the gel’s volume fraction, φ. For compacted clots, the densest of the phys-
iological gels, φ < 0.25, while for non-compacted clots, including arterial thrombi,
φ < 0.1 (Diamond, 1999). Clots can be coarse, with few thick (∼ 500 nm) fibers
separated by large (∼ 20 µm) distances, or fine, with many thin (∼ 100 nm) fibers
separated by short (∼ 1 µm) distances. Figure 2.2 indicates that the distance between
fibers can be ∼ 0.1− 10µm.
In spite of this open space, non-specific chemical adhesion of probes to fibrin prevents
long-distance transport of even nanometer-scale probes. Fibrin is notoriously sticky.
It is used as a tissue adhesive (Saxena et al., 2003), and shows non-specific adhesion
to everything from pipette tips to nanoparticles with carboxylate surface chemistry.
Polyethylene glycol (PEG) has been used to reduce, but not eliminate, the likelihood
of nanoparticle adhesion to fibrin (Valentine et al., 2004). Particles (including enzymes
and drugs) diffusing in a physiological clot typically would interact chemically with
fibrin; free diffusion of chemically active particles could be modeled as an equilibrium
between binding and unbinding events. In addition, enzymes such as thrombin and
plasmin are known alter the gel’s structure. In order to focus on the physical inter-
actions at play in nanoparticle diffusion, this dissertation will focus on the motion of
PEG-coated probes that neither stick to nor alter the gel.
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In summary, for a static flow environment we can reasonably model fibrin as a
random array of rigid rods. This allows me to provide some estimate of how a diffusing
particle will interact with the gel.
2.1.3 Steric diffusion suppression
I will begin with steric interactions. These events occur when the diffusing particle
“bumps” into the gel. How often will this occur? More precisely, how long will we have
to watch a diffusing particle before it collides with a fiber?
Consider a diffusing particle and the nearest fiber, shown in Figure 2.3. We can
ignore all but the nearest fiber because when the bead does collide with a fiber it will,
by definition, be the closest fiber. If the fiber is a distance R from the particle, then






where I have used the generalized diffusion coefficient Deff , because the particle’s diffu-
sion will be determined not by the bulk diffusion from Fick’s laws, but by the viscosity
of fluid in which the particle is diffusing. However, we certainly do not expect that
the particle will always diffuse toward the fiber; in fact, it will diffuse randomly to the
edge of a shell with radius R. After diffusing for a time τR, the probability PR that the
particle will collide with the fiber is the fraction of the shell’s surface occupied by the
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where df is the fiber diameter. If, after τR, the particle has not hit a fiber, then it will
have another shot during the following τR. The probability that it will hit a fiber after
n attempts is unity minus the probability that it never hits, or









= P (τ), (2.7)
















df =  50
df = 250
df = 500
Figure 2.3: Left: A cartoon of the steric diffusion problem. Right: The startup τ
(plain lines) and steric τ (dot-lines) for clots of three fiber diameters (df = 50, 250,
and 500 nm). The collision probability P was calculated from Equation 2.7 for a
500 nm particle in water, and plotted against the average distance to the fibers
R. The lines truncate at the left because the separation between the particle and
the fiber R − (df + d)/2 ≤ 0. Typically, df ∼ 100–250 nm and R ∼ 0.5–5 µm, though
extreme conditions may place clots out of this range.
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To estimate the timescale over which a collision will occur, I can solve Equation 2.7 for











τstartup = 0.46 τsteric. (2.9)
I will call these cases the “startup τ” and the “steric τ”, because these are the timescales
at which a steric effect will begin to manifest, and when it will consistently contribute,
respectively.
For 500 nm particles, then, the startup and steric τ are plotted in Figure 2.3 as
a function of nearest average distance to a fiber R, for several fiber diameters, df .
The plot reveals several key elements of steric diffusion suppression. First, the steric
τ is a very steep function of R, so small changes in clot density are likely to have a
dramatic impact on whether steric diffusion suppression occurs. Second, the transition
region—the difference between the startup τ and steric τ—is not large; it is apparently
less than a decade. Finally, in all but the most dense clots—say, R < 600 nm and
df > 250 nm—steric effects should not be expected to manifest on timescales τ < 1 s.
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2.1.4 Hydrodynamic diffusion suppression
How far must a particle be from a fiber before it starts to feel diffusion suppres-
sion? Specifically, how does the drag on a particle increase as it approaches the fiber
boundary? The ideal toy problem to address this question would be a solution for the
Stokes drag on a particle near a cylindrical boundary. The case of a particle inside a
cylinder has been addressed (Happel and Brenner, 1983; Lee and Ladd, 2005), but I
am not aware of a solution for the rod-sphere case1. However, the bracketing cases of a
particle near a plane and a sphere have been treated; these provide a lower and upper
bound, respectively, on the expected diffusion coefficient for a particle near a cylinder.
The geometry of these cases is summarized in Figure 2.4.
It has been verified experimentally (Kihm et al., 2004; Choi et al., 2007) that a
sphere diffusing near a plane shows hindered diffusion, such that
Dwall = λwallD0 = D0
2λ|| + λ⊥
3
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and β = 2n+ 1. (2.10)
The two-sphere case has been treated for constant-velocity particles (Happel and Bren-
ner, 1983), but the friction coefficient found there (Equation 6–3.51) applies equally


















df =  50
df = 250
df = 500
Figure 2.4: Left: Cartoon summarizing the terms used in the two-sphere and
sphere-plane solutions for diffusion suppression. Right: Diffusion suppression
of a 500 nm particle as a function of distance from a boundary, for three fiber
diameters (df = 50, 250, and 500 nm). Plotted are Dwall/D0 from Equation 2.10
(dashed lines) and Dsphere/D0 from Equation 2.11 (solid lines). The lines truncate at
the left because the separation between the particle and the boundary (z ≤ 0 for
the plane and R − (df + d)/2 ≤ 0 for the sphere) goes to zero. Typically, df ∼ 100–
250 nm and R ∼ 0.5–5 µm, though extreme conditions may place clots out of this
range.
well in this case, because of the low Reynolds number assumptions. Setting the velocity
of the second sphere to zero (recognizing that the fiber is static relative to the diffusing
particle) and inserting df for the diameter of the second sphere, we find,



















The relative suppression, Deff/D0, is plotted in Figure 2.4. As expected, the suppres-
sion from the particle-plane case is greater than that from the two-particle case; the
particle-cylinder case should be somewhere in between these two cases. The absolute
lowest bound is provided by the two-sphere case and the smallest df , 50 nm, which
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shows that at larger values of R—say, above 1 µm, little hydrodynamic effect should be
visible. While this plot cannot truly predict the diffusion of particles in fibrin, it does
suggest that some level of hydrodynamic diffusion suppression should be expected in
most clots, for four reasons. First, the actual hydrodynamic effect will be more severe
than the two-sphere case. Second, clots typically have fibers thicker than 50 nm. Third,
even in clots where R can be very large—say, 10 µm—the particle will spend some time
closer to the fibers, and the diffusion suppresses rapidly as the particle moves closer to
the boundary. Fourth, the hydrodynamic effect—unlike the steric effect—is additive,
meaning that every fiber contributes to the particle’s friction coefficient, not just the
nearest one.
One final comment on the hydrodynamic effect: while the amount of diffusion sup-
pression a particle will experience changes as a function of the particle’s position, it
will manifest, on average, at all τ . This is in contrast to the steric effect, which will
occur only at and above the timescale over which a particle travels from fiber to fiber.
Therefore, on timescales τ < 1 s I expect we will see only hydrodynamic diffusion
suppression.
2.1.5 Expectations for data
Figure 2.5 shows what I expect my data to look like, when both the hydrodynamic
and steric effects are taken together. The hydrodynamic effect occurs at all timescales,
while the steric effect only manifests above the startup-τ .
The 〈r2〉 at which the steric effect begins to manifest must also provide some insight
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Figure 2.5: Cartoon of a theoretical 〈r2〉. The diffusion coefficient is defined
for parts of the curve that have a slope α = 1 (regions I and III). The higher
the intercept of the line, the greater the diffusion coefficient. As discussed in
Section 2.1, at short timescales (region I) the particle interacts only with the
local fluid, but Deff is lower than it would be in free buffer (dotted line) because
of the presence of the gel. After a transition region (region II), steric effects
begin to manifest at longer timescales (region III), resulting in a lower Deff than
at short timescales.
into the fiber density. Conceptually, the range of the 〈r2〉 at the startup and steric τ
should be related to the distance to the nearest fiber 〈r2〉 ∼ R2, as noted in Figure 2.5.
I have used arguments about the way diffusion is determined by gel structure to
motivate Figure 2.5. Gel structure, however, determines more than just diffusion. It
also determines gel permeability. A gel resists fluid flow because of friction between the
fluid and fiber surfaces. These boundary conditions are precisely the ones responsible
the hydrodynamic effect described in Section 2.1.4. Therefore, I hypothesize that if
there is a relationship between gel permeability and particle diffusion, that it will exist
only on timescales where the hydrodynamic effect solely determines Deff , below the
startup-τ , in region I of Figure 2.5.
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2.2 Fibrin Structure and Particle Diffusion
We now have a broad picture of what physical phenomena govern particle diffusion
in clots, and the timescales on which they are relevant. In this section I expand on the
toy problems of Section 2.1 by highlighting specific models of particle motion in models
of fibrous materials.
2.2.1 Ogston Model: diffusion with steric hinderance
Consider fibrin to be a simple porous network, invariant in time, with a rigid scaf-
folding submerged in a background fluid, in which solute particles can move. Ogston
considered solute diffusion in a matrix of randomly oriented rods (Ogston et al., 1973).
He presented a stochastic argument, closely following Einstein’s 1905 approach. In
Ogston’s treatment, however, the presence of the rods sometimes prevent the particle









where D0 is the diffusion coefficient of the particle in pure background fluid, φ is the
volume fraction of the gel, and df is the diameter of the rods that form the matrix. The
predicted quantity, Deff , is the particle’s actual diffusion coefficient, which the theory
indicates will be below D0 due to the presence of the gel; this is shown in Figure 2.6.
Note that moving to coarser clots—increasing df at constant φ—restores the effective
diffusion coefficient closer to D0. This is because if the fibers get thicker while the
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volume fraction remains steady, then the number of fibers must be decreasing; this in
turn, corresponds to an increase in the size of the open spaces (captured by the quantity
R in Section 2.1).
Figure 2.6: Two models of diffusion suppression for a 500 nm particle in a gel
of varying fiber diameter (df = 50, 250, and 500 nm) as a function of volume
fraction. The range 0.01 < φ < 0.2, is typical for fibrin gels. Top: The Ogston
model (Equation 2.12) (solid line), plotted with the steric-only term of the Phillips
Model S(f) (dots). The numerical solution in S(f) does not agree with the Ogston
model, but the reason for the disagreement is not well-explained in the litera-
ture. Bottom: The Phillips Model (Equation 2.13) (dashed line), plotted with its
hydrodynamic-only term F (stars). Also plotted is the df = 50 nm case for S(f)
(dots). Comparing S(f) and F shows that at low volume fraction, the diffusion
suppression is primarily hydrodynamic, but as the gel becomes more dense, the
steric effect comes to dominate the supression.
At the time, Ogston showed that this theory explained experimental data of particle
sedimentation in hyaluronic acid, in a system where d/df ≈ 1.4. It has been revisited
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regularly—recently, see (Johnson et al., 1996; Williams et al., 1998)—but I am not
aware of research testing its relevance in fibrin diffusion. The Ogston model accounts
only for steric interactions, and ignores any hydrodynamic effect that the gel might
have on the background fluid. Yet Figure 2.5 explains that we expect the hydrodynamic
effect to be present at all timescales. In Chapter 3 I show that the Ogston Model is
not consistent with my data, as expected.
2.2.2 Phillips Model: a numerical solution
More recently, Phillips provided a simple formulation for diffusion suppression that
accounted for both hydrodynamic and steric interactions with the gel (Phillips, 2000).
Phillips used his prior work simulating the hydrodynamic effect for particle diffusion in
a liquid-filled, three-dimensional medium of randomly placed cylindrical fibers (Clague
and Phillips, 1996), and combined it with the results of a simulation of the steric effect







, S(f) = e−0.84f
1.09
a = 3.727− 2.460λ+ 0.822λ2
b = 0.358 + 0.366λ− 0.0939λ2 (2.13)
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where F is a term that captures hydrodynamic diffusion suppression, S(f) captures
the steric diffusion suppression, f = φ(1 + 1
λ
)2, and λ = df/d.
We can apply this model to fibrin diffusion data whether hydrodynamic or steric
effects are responsible. As with the Ogston Model, the Phillips model has not been
tested against diffusion and structural data from fibrin gels. Because of the inherent
challenges of determining clot structure from microscopy, the validation of this theory
in fibrin is outside the scope of this dissertation. However, in Section 3.3.1 I show that
the Phillips model can be inverted, along with the Carman-Kozeny and Jackson-James
theories (see Section 2.3), to provide a reasonable prediction of clot structure.
The Phillips model, along with its constituent terms, S(f) and F , is plotted in
Figure 2.6. Except for the limiting cases of φ → 0 and φ → 1, S(f) does not agree
with the Ogston model as one might expect; unfortunately, this issue is not explained
in the literature. At low φ, the hydrodynamic term F is the one that dominates the
diffusion suppression; the steric term S(f) matches (then overtakes) the hydrodynamic
suppression at volume fractions of φ = 0.005–0.2, depending on df . Fibrin volume
fractions are within this range, so Figure 2.6 suggests that steric diffusion suppression
should be a factor in fibrin, but only if the transport is above the steric-τ .
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2.3 Fibrin Structure and Hydraulic Permeability
2.3.1 Darcy Theory
Gels and porous media resist, but do not fully arrest, the flow of fluid. In 1856,
Henry Darcy published a treatise on the public fountains of Dijon, France, which in-
cluded exploration of how a filtration system (sand, in the case of his experimental
design) resisted the flow of fluid (Darcy, 1856). The observations of Darcy’s original
experiments can be generalized for permeants of arbitrary viscosity η and for perme-





where Q˙ is the volumetric flow rate, A and L are the cross section and length of
the filter, and ∆P is the pressure drop across the filter. The coefficient κ has units
of area and is called the hydraulic conductivity, or Darcy constant; I will use these
terms interchangeably with “permeability”. The permeability of a classical porous
medium is invariant with the other parameters in Equation 2.14. If, for example, ∆P
were increased across a gel, then Q˙ would increase in direct proportion, such that the
calculated κ would not change.
Blomback and Okada were among the first to recognize the potential value of mea-
suring permeability of fibrin (Blomba¨ck and Okada, 1982). Since that time, the cor-
relations of clot permeability with disease have established permeability as a critical
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measurement, as discussed in Section 1.1.
The Darcy equation, though a powerful tool, is wholly phenomenological. In the
century and a half since his observations were published, much effort has been devoted
to predicting κ using information about the material’s structure. Initial work in the
late 19th and early 20th centuries considered a porous medium to be a collection of
capillaries. Intuitively, the volume fraction of the medium could be accounted for by
the effective diameter of the capillaries relative to the cross-section of the medium, and
the tortuosity of the flow through the medium could be accounted for by the effective
length of the capillaries relative to the length of the medium.
2.3.2 Carman-Kozeny relation
The history and usage of the capillary model is described concisely by Carman (Car-
man, 1937), who provided a simple expression for the Darcy constant κ as a function
of S, the surface area per unit volume presented to the fluid, and a Kozeny factor k








in his work, Carman explained the relationship between S and df . The task, then, is
to predict k. For fibrous gels, a Kozeny factor may be assembled after determining the
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. (2.16)
Combining Equations 2.15 and 2.16 gives κ as a function of volume fraction φ, shown
in Figure 2.7.
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Figure 4 - A comparison of three-dimensional models for fibrous 
porous media. 
single cylinder problem, they used the Brinkman-Debye- 
Bueche (BDB) equation: 
v p  = p i 7  - 14V 
k 
which is the superposition of Stokes equation and Darcy’s 
law. The velocity was required to vanish at the cylinder and 
to match the superficial velocity at infinity. Having avoided 
Stokes’ paradox because the Darcy term is dominant at large 
distances, they found the flow field and drag on an infinitely 
long cylinder. From the drag, the equivalent permeability 
was determined and this was taken to be the permeability k 
in the governing equation. Hence an implicit relation was 
found for k: 
where K,, and Ki are modified Bessel functions of the second 
kind. This equation is plotted in Figure 3 and the curve lies 
about 25% above the accurate collective curve. 
This novel approach of Spielman and Goren-now gen- 
erally referred to as ‘swarm’ theory-led to a number of 
works which attempted to improve the concept. Howells 
(1974) extended the analysis by including a second fiber at 
random locations and accounting for its influence. His re- 
sults agree with those of Spielman and Goren for + 5 0.3, 
and give lower permeabilities at higher +. Neale and 
Masliyah (1975) and Guzy et al. (1983) supposed that there 
is a fluid annulus around the single cylinder, inside of which 
Stokes’ equation applies and outside of which either Darcy’s 
equation or the BDB equation applies. This approach is, in 
effect, a combination of the circular cell model and the 
two-zone concept of Spielman and Goren. Matching condi- 
tions at the edge of the envelope depend on which equation 
is specified for the outer region, but the resulting two pre- 
dictions differ little for 4 < 0. I ,  as Guzy et al. show. If the 
two predictions were plotted in Figure 3, the curves would 
fall between the Happel curve and the collective curve 
(Kuwabara, etc.). The main point is that these refinements 
to a model flow do lead to results which are closer to the 
accurate solutions, i.e., to those of Hasimoto, Sangani & 
Acrivos and Drummond & Tahir. 
FLOW THROUGH THREE-DIMENSIONAL ARRAYS 
Spielman and Goren used the same technique to estimate 
the permeability of rods randomly oriented in all three direc- 
tions. They solved the problem of a rod oblique to the 
superficial velocity by allowing the permeability to have 
different values in the directions parallel and perpendicular 
to the flow. Then, by averaging over all rod directions, they 
determined the permeability of this three-dimensional 
medium. Using the same notation as before, this result is 
The only other work on three-dimensional arrays appears 
to be our own development of a cubical lattice model (Jack- 
son and James, 1982). In that work, it was argued that the 
permeability of a random medium like steel wool is equiv- 
alent to the permeability of a cubical lattice formed of the 
same material. The flow resistance of the lattice was esti- 
mated by adding the resistance of rods across the flow to that 
of rods aligned with the flow. The individual resistances 
were calculated from Happel’s relations and an overall per- 
meability was predicted. Now that Drummond and Tahir’s 
more accurate equations are available, we now present a 
revised prediction for k/a’ ,  based on their Equations (2) and 
( 1 I ) for square arrays: 
3 - = - (-In + - 0.931 + O(ln + ) - I )  . . . . . . . 
a* 204 
This equation and Spielman & Goren’s result (Equation 15) 
have been plotted in Figure 4. It is apparent that the two 
models agree reasonably well with each other and with the 
experimental data. 
Conclusions 
The conclusions of this work are best stated with refer- 
ence to the figures: 
(i) Figure 1. The graph shows that permeability data for 
diverse fibrous materials are correlated reasonably well 
when the co-ordinates k /a2  and 4 are used. The scatter 
is caused by inhomogeneity and by variations in fiber 
shape and arrangement. For example, if the graph could 
be restricted to media with uniformly distributed fibers, 
or to media where the fibers had a single orientation, 
then the scatter would be reduced considerably. Even 
with the scatter, though, the graph is useful for order of 
magnitude estimates of flow resistance when flow data 
are not available for a porous material but when fiber 
size and volume fraction are known. 
(ii) Figure 2. For arrays of parallel fibers aligned with the 
flow, predictions by all analytical techniques agree 
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Figure 2.7: Left: κ(φ), according to the Carman-Kozeny (solid), Jackson-James
(stars) and Davies (dots) relations. The theories are easier to compare by nor-
malizing away the fiber diameter. None of thes quations has been convincingly
demonstrated to predict fibrin permeability. Right: The Jackson-James equa-
tions has been validated in other fibrous materials over a wide range of φ. Criti-
cally, over the relevant range of φ for clots—say, 10−3–10−1—all three theories are
essentially within the scatter of the data used by Jackson and Ja es.
This theory has been validated in fibrous gas filte s (Fowler and Hertel, 1940) and
beds of aligned cylinders (Astrom et al., 1992). It remains in regular use, including
in agarose gels (Pluen et al., 1999) and extra-cellular m tr x (Peders n e al., 2007),
and collagen (Ramanujan et al., 2008). However, it has not been validated in fibrin;
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because of the inherent challenges of determining clot structure from microscopy, the
validation of this theory in fibrin is outside the scope of this dissertation. However, in
Section 3.3.1 I show that the Carman-Kozeny theory can be inverted, along with the
Phillips Model, to provide a reasonable prediction of clot structure.
2.3.3 Fibrous media: Jackson-James and Davies equations
In an effort to find a solution specific to fibrous media, Jackson and James (Jackson
and James, 1986) offered another theoretical solution. They constructed a model using
prior theories of flow parallel (Sangani and Acrivos, 1982) (numerical) and perpendic-
ular (Drummond and Tahir, 1984) (analytical) to rigid rods in a square lattice. They
applied their equation to data on a wide variety of fibrous networks, including steel
wire crimps, wool, yarn, filters, acrylamide gel, collagen, and hyaluronic acid polymer.
The volume fractions ranged from 0.0003 < φ < 0.3. While fibrin were not included
in the fit, the wide variety of fibrous materials used to create the equation suggests it







Figure 2.7 shows that the Jackson-James equation shows good agreement with the
Carman-Kozeny theory for random arrays of rods.
I have found one example in the literature where fibrin has been tested against a
theory of κ(φ). Diamond and Anand compared fibrin permeability for several types of
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concluding that this equation “accurately correlated” data that they had extracted from
earlier published results on fibrin permeability and imaging. However, neither the data
nor the method used to extract them were reported, so I cannot say to what precision
the Davies equation has been validated. Even more alarming, their citation leads to
an equation 4.1.8 in a text (Dullien, 1992) where the coefficients differ from those of
Equations 2.18, and the citation is an article I have not been able to find to resolve
the discrepancy. Because of its prior use in fibrin, I will bring Equation 2.18 through
my discussion in Chapter 3. However, as theoretical rather than empirical models, the
Jackson-James and Carman-Kozeny theories are ultimately more satisfying.
The ultimate question, however, is which equation is correct; therefore I stress that
the Davies, Jackson-James, and Carman-Kozeny equations, all plotted in Figure 2.7, do
not disagree dramatically over the relevant range of fibrin volume fractions (φ = 0.001–
0.1). In this range, the theories all appear to lie within the scatter of the data used to
determine the Jackson-James equation.
I must also stress that direct validation of any κ(φ, df ) theories is challenging,
because measuring fibrin fiber diameter and volume fraction is notoriously difficult.
Optical microscopy can image fibrin without drying, but it loses reliability for size
detection below the diffraction limit. Electron microscopy can easily resolve specimens
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of that size, but the fibers must be dried before they can be imaged, in which case they
shrink and frequently collapse. Therefore, as an alternative to imaging based methods,
I show in Chapter 3 that by inverting these theories, measurements of diffusion and
permeability can provide insight into clot structure (df and φ).
2.3.4 Permeability and turbidity
I am discussing theories that predict κ(φ, df ). As explained in Section 1.1, turbid-
ity has been mentioned as a high-throughput measurement of clot structure. Could
turbidity therefore be used to find permeability?
The early work on light transmission through fibrin was traditional angle-dependent
light scattering (Carr et al., 2004). This work did indeed reveal fiber lengths and
diameters, but not all the fibrin studied were polymerized gels.
Carr and Hermans introduced fibrin turbidity shortly after, presumably because it
is simpler to perform than angle-dependent light scattering. Turbidity of a solution is
the decrease in transmitted light intensity due to scattering and can be calculated by







where Ti is the turbidity at the start time, ρ0 is the fibrinogen concentration, λ is
the incident wavelength, µ is the linear mass density of the fiber (sometimes called











where NA is Avogadro’s number.
The angular integration that makes turbidity so convenient as a methodology ruins
its potential as a complete probe of gel structure—namely, of φ and df . Consider the







where nf is the number density of fibers and Lf is the length of an average fiber. The
problem is already apparent: Equation 2.20 has three inputs, but turbidity provides


















where Vf is the volume of the fiber, mf is the average fiber mass, m is the mass of a
fibrin monomer, and N is the average number of fibrin monomers in a fiber. Eliminating
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where ρ is the density of monomers in the fiber. This last quantity, ρ, is essentially
the packing of fibrin monomers in a fiber, and it is unknown. Fibrin fibers are under
tension, and that tension may increase as fiber diameter increases (Weisel, 2004), which
would cause ρ to scale with N . Studies with AFM of dried fibrin fibers have indicated
that the fiber density varies with the radial distance from the axis of the fiber (Guthold
et al., 2007). For these reasons, we cannot assume that ρ is constant. Thus, turbidity
cannot provide sufficient information to extract gel structure.
The coagulation community relies heavily on turbidity for understanding of clot
structure, and has built an intuition of how turbidity and permeability are related2. I
will linger on this topic to highlight a potential hazard in the way the measurement
is presently used. For two clots with the same polymerization rate, but different final
transmission, there is ambiguity in the clot structure, highlighted in Figure 2.8. The
lower final turbidity could be due either to a lower clot volume fraction at a constant
fiber diameter, or to a smaller fiber diameter at a constant volume fraction. The first
2My thanks to Alisa Wolberg for helpful conversations on this topic.
36
case is achieved by reducing the number density of fibers; this would result in a higher
permeability. The second case is achieved by increasing the number density of fibers;
this would result in a lower permeability.
Figure 2.8: Turbidity provides a glimpse into gel structure. Compared with some
reference clot (curve A), faster polymerization (indicated by faster rise times,
curve B), implies a finer clot. A lower final turbidity (curve C) could be due
to lower φ (lower fibrin concentration), which would correspond to a clot with
greater permeability than the reference clot. However, lower final turbidity could
also be due to smaller fiber diameter (higher thrombin concentration), and this
type of clot would be expected to have a lower permeability.
The ambiguity becomes particularly treacherous as more biochemical factors are
introduced. Consider, for example, the relationship between turbidity and permeability
for clots formed in the presence of aspirin (Ajjan et al., 2009). Electron microscopy
shows that clots formed in the presence of aspirin have a coarser structure with thicker
fiber diameters, which is similar to the changes in clot structure achieved by decreasing
thrombin concentration, but without the change in clotting time. Aspirin does not
change clotting rate, but it increases the final turbidity. Is this because aspirin promotes
lateral aggregation, decreasing number density of fibers and increasing permeability?
Or is it because aspirin alters lateral aggregation in some fashion, causing fibers to
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swell without changing their number density, causing no affect or a small decrease in
permeability? The complexity of the system leaves open questions which turbidity
alone cannot answer.
2.4 Diffusion and Permeability
A wide range of scientists and engineers are concerned simultaneously with fluid
permeation and particle transport through a medium. The filtration community is
concerned less with particle diffusion than with the rejection rate of particles moving
through a barrier (Zamani and Maini, 2009), and therefore pore sizes in the filter are
typically designed to be smaller than the particles expected to be passing through,
hydrodynamic effects are typically ignored, and electrostatic effects are considered in
detail (Wijmans and Baker, 1995; Szymczyk and Fievet, 2005). Geological sciences
consider gas perfusion through soil and rock (Hamamoto et al., 2009), but pressure-
driven advection make dispersion, or mixing, a more relevant phenomenon than in gels
studied in vitro. Novel device research can present an interesting area of overlap, as
some research considers how adding nano-devices to bulk material can enhance particle
diffusion or modify bulk permeability (Zhong et al., 2003; Srebnik and Sheintuch, 2009).
There is great interest in these two measurements in polymer gels community. Col-
lagen, extracellular matrix, and agarose have all been studied for this relationship (Ra-
manujan et al., 2008; Pedersen et al., 2007; Pluen et al., 1999; Levick, 1987). In these
experiments, the question is typically whether particle diffusion can be predicted from
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permeability; the latter being a bulk measurement that requires no specialized equip-
ment. However, absent from the discussion about the relationship between the two
phenomena is the time- and length-scale dependence over which diffusion occurs will
have a dramatic impact.
Consider an effort to predict the speed of inter-cellular communication for cells
embedded in extracellular matrix. The distances are short—perhaps just tens of
nanometers—so steric effects between the diffusing molecule and the gel may not be
relevant, producing faster diffusion and therefore faster communication. Hydrodynamic
effects would still be present. Permeability is also a hydrodynamic effect. An equation
that linked hydrodynamic diffusion suppression with permeability could predict the
speed of this communication by measuring bulk gel permeability, which might be easier
than a nanometer-resolution, high-bandwidth measurement of diffusion.
Fibrin presents a convenient system to confirm such a theory, because the inter-fiber
distance is measured in hundreds of nanometers or more, where for some polymer gels
the distances can be tens of nanometers or smaller.
Furthermore, a relationship between permeability and diffusion would be especially
useful for coagulation science, because it presents the possibility that clot permeability
could be measured in high throughput. There is indeed a theory that relates Deff and
κ. In addition to establishing a relationship between these quantities, it can also help
isolate whether hydrodynamic or steric effects are dominating particle diffusion.
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2.4.1 Effective medium theory
In 1949, Brinkman presented an “effective medium” theory to determine the force
on a granule suspended in a fluid-filled porous medium (Brinkman, 1949). He assumed
nothing about the medium except that it had a permeability κ. In his treatment,
the continuity condition on the fluid velocity at the edge of the pocket in which the
granule was located increased the friction on the granule—in short, it was a model for
the hydrodynamic effect discussed in Section 2.1.4. The theory is valid in the regime
φ < 0.6, which comfortably encompasses the full range of fibrin and plasma clots, and
many whole blood clots.
Is the hydrodynamic effect modeled in the effective medium theory valid for a diffus-
ing particle? This was the supposition of Phillips (Phillips et al., 1989), who presented











where D0 is the diffusion coefficient of the particle in solvent, d is the particle diameter,
and κ is the Darcy coefficient of the gel.
Equation 2.25 is essentially phenomenological. The equation has no fundamental
gel structure (e.g. φ or df ), only the empirical quantity κ. I discuss this theory
because permeability is a well-established measurement in clots, so the effective medium
theory will be straightforward to test. By contrast, there is no validated technique for
measuring φ in clots, and techniques for measuring df are questionable, perhaps to
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within a factor of two, due to the potential effects of drying (electron microscopy) or
deconvolution (confocal microscopy). These experimental challenges present limitations
on the accuracy with which the above theories of Deff(φ, df ) and κ(φ, df ) could be tested
directly.
Because the effective medium theory only models hydrodynamic diffusion suppre-
sion, its validity would show that hydrodynamic, rather than steric effects, were deter-
mining particle diffusion. This result would be an important first step toward identify-
ing which of the Deff(φ, df ) and κ(φ, df ) were relevant.
It has been suggested, but not demonstrated, that effective medium theory applies
to nanoparticle diffusion in fibrin (Diamond, 1999). The effective medium theory has
been tested in agarose, where it was found to overestimate Deff/D0 (Johnson et al.,
1996). The issue in agarose appeared to be that steric effects were ignored. Using
Equation 2.25 as F from Equation 2.13 improved agreement. In Chapter 3, I explain
that this prior work was observing diffusion at timescales longer than the steric-τ . In
my work, I use a higher-bandwidth single-particle tracking technique, which measures
Deff over sub-micron distances. I show that the data appear to be within the startup-τ ,
and show that the effective medium theory therefore holds in fibrin gels.
2.5 Conclusion
For a fibrin gel, which may plausibly be modeled as a low-volume fraction, rigid
rod matrix, I have discussed the theoretical landscape connecting structure, diffusion,
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and permeation. The relevant models are summarized in Figure 2.9. The Ogston
and Phillips models both predict diffusion suppression as a function of gel structure.
However, the Ogston model accounts only for steric supression, where the Phillips
model accounts for both steric and hydrodynamic interaction.
Model









Deff / D0 ϕ, df no Stochastic physical model Steric effects
Deff / D0 ϕ, df no Numerical physical model
Steric and 
hydrodynamic effects
κ ϕ, df no Analytical physical model
Steric and 
hydrodynamic effects
κ ϕ, df other fibrous materials
Empirical fit to regular 
rigid rod lattice model
N/A
κ ϕ, df some fibrin clots Empirical fit N/A
Deff / D0 κ no Semi-empirical model Hydrodynamic effects
Figure 2.9: Summary of the models under consideration.
The effective medium model is a semi-empirical equation that connects diffusion and
permeability. It accounts only for hydrodynamic suppression of the diffusion coefficient.
It is useful because well-established methods exist for measuring fibrin permeability,
and it should be straightforward to test this theory’s validity. If the effective medium
theory applies, we should ignore the (wholly steric) Ogston model in favor of the Phillips
model.
After measuring diffusion and permeability, it should be possible to use appropriate
equations for Deff/D0 and κ to estimate φ and df . In Chapter 3, I will measure fibrin
permeability, structure, and diffusion, and in this manner establish the relevance of the
theories above to fibrin gels.
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Chapter3
Transport in Fibrin: Experiments
To evaluate the relevance of the theories in Chapter 2, I have measured the diffusion
coefficient Deff and permeability κ in the clots of Figure 2.2. In this Chapter I test the
relevance of the effective medium theory, then apply the Phillips and Davies models
to extract the clots’ structure. I demonstrate that, as expected the effective medium
theory can be applied to measure clot permeability in high throughput. I explore how
diffusion can be used to reveal information about gel structure. Finally, I discuss the
implications of my results on drug design and delivery.
Diffusion will prove useful as a clot characterization assay only insofar as it is sen-
sitive to relevant clot properties. In this chapter I demonstrate that with the correct
probe size, Deff varies across concentrations of fibrinogen (0.5–3 mg/mL) and throm-
bin (1–10 nM). As Figure 2.2 shows, clots formed under these conditions span a wide
range in gel structure. I also measure diffusion in platelet-poor plasma (PPP), which
bolsters this assay’s physiological relevance and broadens the usefulness of the assay for
coagulation science, as PPP is easier and cheaper to prepare than purified fibrinogen.
The PPP gels I study are prepared from plasmas collected from normal individuals
and hemophilic patients. Hemophilia is a genetic disorder that manifests as hypo-
coagulability due to a deficiency of either FVIII or FIX. (This specimens in this study
suffer from FVII deficiency.) It can be treated by the addition of activated recombinant
FVII (rFVIIa), which should restore clotting function. The phenotype of the disorder
and of the treatment were shown in Figure 2.2: the normal clots are finer than the
hemophilic clots, and rFVIIa partially restores some of the normal clot structure. The
specimens in this study were acquired from A. Wolberg and prepared with the help of
R. Campbell.
3.1 Measuring nanoparticle diffusion
In an effort to separate physical from chemical interactions, I employed nanopar-
ticles with polyethylene glycol (PEG) surface treatment, which have been shown to
reduce particle-protein affinity (Valentine et al., 2004). Reagent handling, specimen
preparation and experimental setup is explained in Appendix A, and summarized in
Figure 3.11. Briefly, purified fibrinogen, human α-thrombin (Enzyme Research Lab-
oratories, South Bend IN), and nanoparticles (Invitrogen, Carlsbad CA) with PEG
surface chemistry are diluted in HEPES-buffered saline (HBS: 20 mM HEPES, pH 7.4,
150 mM NaCL), and mixed to trigger fibrin gel formation. Gels are prepared in a
96-well, optical-bottom microplate (Matrical, Spokane WA), and allowed to polymerize
1I am greatly indebted to Rachel Sircar for her tireless work PEGylating particles, tracking particles,
and most importantly, refining the diffusion protocols described in this chapter.
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for 2 hours. The microplate is placed on an inverted widefield fluorescence microscope,
where videos of particle diffusion are acquired from five fields of view for 60 s each.
Particle trajectories are automatically tracked with CISMM Video Spot Tracker, then
filtered for tracks that last less than 2 s. The quantity 〈r2〉 is calculated for a range of
lag times ranging from about 1 ms–10 s.
Figure 3.1: Top: Experimental pipieline for diffusion experiments. To simplify
mixing and data collection, clots are prepared in a 96-well microplate. Bottom
left: a typical frame out of a video of diffusing 500 nm particles. Bottom right:
a maximum intensity projection, showing how diffusing particles sweep out some
area over a period of time. Each image is 140 µm on a side. Dots are brighter
when the particle is more in focus, so the dimming and blurring that produce
the sense of perspective are not wholly misleading.
Video capture and automatic single-particle tracking generates thousands of parti-
cle paths. Typical particle paths and the resulting plot of 〈r2〉(τ), shown in Figure 3.2,
reveals the heterogeneity of the particles’ environment, as well as highlighting errors of
the auto-tracking algorithm. Issues with auto-tracking, and other subtleties of transi-
tioning to high-throughput diffusion measurements, are discussed in Chapter 5.
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Figure 3.2: Overview of the data analysis pipeline, showing how stuck and freely
diffusing particles are represented at various stages of the analysis. Left: Typical
particle paths for particles with and without PEG surface chemistry. Middle:
Particle trajectory r(t) for a freely diffusing and a stuck particle. The freely
diffusing particles move farther from their original location (r = 0) and are usually
tracked for shorter periods of time, because they diffuse out of plane. Right:
Mean squared displacement 〈r2〉 from a typical specimen of 500 nm PEG particles
in 1 mg/mL fibrinogen and 10 nM thrombin. To improve legibility, only 20% of
tracks are plotted. There are two core populations: freely diffusing (α → 1)
and stuck (α → 0) tracks. Errors of the auto-tracking algorithm produce outlier
tracks, discussed further in Section 5.2.1. The noise floor for this measurement
is ∼ 10−3µm2 at all τ < 1 s, representing particle motion of 32 nm.
3.1.1 Diffusion in fibrin is size-dependent and bimodal
Figure 3.3 indicates that the diffusion of particles in fibrin is bimodal. The majority
of particles diffuse freely (α→ 1). This behavior is statistically equivalent to particles
diffusing in a purely viscous fluid. The remaining particles have a dramatically lower
powerlaw dependence (α→ 0), indicative of a “stuck” particle.
Nanoparticle diffusion varies when the particle size is changed from 200 nm to 1 µm,
as shown in Figure 3.4. The percentage of stuck beads is typically larger in finer clots,
or with increasing fibrin concentration. However, the relative size of the free and stuck
populations is not stable. Occasionally I observe clots with a high percentage (> 50%)
of stuck particles when there was no apparent difference in the preparation or structure
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1mg/mL fibrin, 10nM thrombin
Figure 3.3: The behavior of diffusing beads in fibrin (red bars) is bimodal. α→ 1
for most particle traces, and a distinct population shows sub-diffusive behavior.
“Freely diffusing” particles are defined as those with 0.8 < α < 1.2. Diffusing
particles in buffer (blue bars) and random-walk simulations (cyan bars) have no
stuck population. The buffer data is centered slightly above α = 1 due to small
amounts of drift generated by the fluorescence illumination.
of the clots themselves. Such results were more common in platelet-poor plasma (PPP)
clots than in purified fibrin clots.
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Figure 3.4: 〈r2〉 for particles from 0.2–1 µm. As particle size decreases, so does
the percentage of stuck tracks. Stuck tracks are identified by a lower powerlaw
(slope), α. Also, the distance the particles diffuse (vertical position of lines)
increases.
We verified that free diffusion on the micron scale can produce long-distance trans-
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port. We prepared clots where the particles were not present during gel formation.
Clot formation was measured using turbidity, shown in Figure 3.5, which showed that
all clots types reached final absorbance after 2 hours; in this and all subsequent ex-
periments, 2 hours was taken to be the incubation time for clot formation. After clot
formation, 500 nm particles were placed above the clot. The clots were ∼ 1 mm in
height, determined by using a long working distance objective to find particles at the top
of the clot. Particles first became visible at the other side of the clot (< 100 µm from the
coverglass) at about 24 hours. The concentration of particles near the coverglass stabi-
lized after ∼ 72 hours. implying a bulk diffusion coefficient Dbulk = x2/τ ∼ 1 µm2/s,
where x and τ are the first passage distance and first passage time, respectively.
Figure 3.5: Turbidity is a common measurement of gel formation. The higher
the final absorbance, the thicker the fibers. When the fibers are finished aggre-
gating, the absorbance stops increasing, creating the plateaus seen in these plots.
Formation of the 1 mg/mL fibrinogen, 1 nm thrombin clot (teal, right-hand plot)
took two hours, which determined the incubation time for gel formation.
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3.1.2 Sensitivity to clot structure
We measured nanoparticle diffusion in a range of purified gel types, from low to
high thrombin concentration (1–30 nM) and low to high fibrinogen concentration (0.5–
3 mg/mL), with the two particle sizes (d = 260 and 500 nm) that have populations
where α → 1. For these freely diffusing particle traces, we calculated Deff from Equa-
tion 2.2. Although 〈r2〉 ∝ τ 1 is indicative of free diffusion, the fibrin gel apparently
suppresses the particles’ motion: where D0 = 0.94 ± 0.02µm2/s for 500 nm particles
in water, Deff drops with decreasing clot coarseness, reaching 75% of D0 in 1 mg/mL
fibrin and 30 nM thrombin and 58% of D0 3 mg/mL fibrinogen, 10 nM Thrombin.
In a purely viscous fluid, D = kBT
3piηd
, where kB, T , and η are Boltzmann’s constant,
absolute temperature, and the dynamic viscosity, respectively. Therefore, the product
dDeff is a function exclusively of specimen parameters, and any variation with particle
size could be interpreted as a variation in the effective viscosity or temperature of the
particle’s environment. Results for dDeff of 500 and 260 nm particles are shown in
Figure 3.6. In coarser clots (namely, 1 mg/mL fibrinogen with 0–5 nM thrombin, and
0–0.5 mg/mL fibrinogen with 1 mg/mL thrombin), particles of both sizes experience a
similar environment that is effectively more viscous than pure buffer. As the clots grow
finer, the diffusion of 500 nm particles drops faster than that of 260 nm particles.
Nanoparticle diffusion in platelet-poor plasma (PPP) clots is also sensitive to struc-
ture. We measuredDeff for normal (0.51±0.005 µm2/s), hemophilic (0.58±0.007 µm2/s),
and recombinant factor VIIa (rFVIIa)-treated hemophilic (0.57±0.005 µm2/s) clots. In
agreement with the correlation seen in purified fibrinogen gels, the diffusion is greater in
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Figure 3.6: Deff of freely diffusing (α = 1) nanoparticles is sensitive to clot struc-
ture. Left: Diffusion under varying fibrinogen concentration (thrombin con-
centration 10 nM). Deff of 500 nm particles (solid), diverges from buffer value
(0 mg/mL fibrinogen) with increasing thrombin concentration. 260 nm particle
diffusion (dash-dot) is also suppressed by the gel, but the particles are less sensi-
tive to the changes in gel structure. Right: A similar effect occurs with 260 nm
and 500 nm particles under varying thrombin concentration (fibrinogen concen-
tration 1 mg/mL). In both graphs, the dashed line is the theoretical prediction
of dDeff for a sphere diffusing in water. In a homogeneous material, the quantity
dDeff for two particles of different sizes is expected to be invariant. As this is not
the case, nanoparticles of different sizes effectively experience different surround-
ings. Number of trackers N > 500 for each data point; bars show 95% confidence
intervals.
the coarser hemophilic clots as compared with the finer normal clots. rFVIIa has been
shown to partially restore the clot structure and stability that is lost in hemophilic
clots (Wolberg et al., 2005), and we observe that the rFVIIa treatment also partly
restores diffusion to its normal value.
There is a possibility that the presence of particles during gel formation might alter
the kinetics of gelation. I tested clots both with particles diffusing into the clot from
above, and with particles present from the start of polymerization. Figure 3.7 shows
that the presence of nanoparticles during polymerization does not substantially affect
the measurement.
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Figure 3.7: Results for Deff are similar whether particles diffuse into a fully formed
clot (solid line), or are present during gel formation (dotted line). Particles are
500 nm. The dashed line is the theoretical value for diffusion in buffer. Number
of trackers N > 500 for each data point; bars show standard error.
3.1.2.1 Statistical Significance
The short time over which I can track the particles (typically 2–5 s) results in a
naturally large standard deviation σd behind each datapoint in Figure 3.6; it is often
more than twice the differences in mean diffusion coefficient that these measurements
reveal. However, the large sample population (> 500 trackers for each clot type) allows
a high-confidence measurement. In my analysis, I calculate the standard error σe, de-
fined as standard deviation divided by the square of the population size. The standard
error is the standard deviation expected in the mean in the event that I repeatedly per-
formed the same measurement on an identical specimen. The 95% confidence interval
(equivalent to a p-value of 0.05) of a normal distribution is 1.96 standard deviations.
Therefore, the 95% confidence interval for the diffusion coefficient is







D¯2i − D¯i2, (3.1)
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where Di is the Deff calculated for each tracker. It is this 95% confidence interval that
is plotted as error bars in Figure 3.6.
3.1.3 Long-time diffusion
Particles are typically tracked for less than 5 seconds, because the depth of field is
about 4 µm and Deff ∼ 1 µm2/s. Tracking particles for longer requires dynamically
adjusting the imaging plane. I am indebted to R. Schubert’s efforts in creating Z-
Chaser, a software algorithm that accomplishes this task using a three-axis piezoelectric
stage. We have used Z-Chaser to track particle motion2 for up to 10 min. Clots were
prepared, video was acquired and tracked, and data were analyzed as described above.
The resulting 〈r2〉(τ) is plotted in Figure 3.8.
At short timescales (< 1 s), the particles of Figure 3.8 have a slope α = 1, similar to
the particles tracked in Figure 3.4. Unlike those experiments, however, these particles
generally maintain a stable α for τ < 80 s, where the particles tracked for short times
(fixed focal plane) show scatter in α around τ > 1 s. This disparity is due to the shorter
observation time, which leads to more random 〈r2〉 measurements near the long-τ end
of these plots.
Interestingly, two particles in the densest clots show a downward concavity that
begins above 10–20 s. One possible explanation is that the particles have moved far
enough (1–10µm, according to Figure 3.8) to collide with the fiber mesh; these steric
interactions would manifest as timescale-dependent collisions, causing suppression in
2I am indebted to Elizabeth Littauer for her work collecting fibrin diffusion data using Z-Chaser
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Figure 3.8: 〈r2〉 for particles tracked for longer than 1 min. Clots were 10 nM
thrombin with 0.5 mg/mL (blue), 1 mg/mL (green), or 3 mg/mL (red) fibrinogen.
Most tracks show no meaningful deviation from the short-time diffusion statistics.
However, two particles in the densest clots (bold red lines) show a downward




Clot permeability was measured3 using a simple constant-pressure design, as shown
in Figure 3.9.
Clot permeabilities were in the expected range for purified clots—for example,
see (Blomba¨ck and Okada, 1982). As expected, the permeability dropped as the num-
ber density of fibers increased (i.e., finer clots), as measured at a range of thrombin and
fibrinogen concentrations. The permeabilities measured are summarized in Figure 3.10.
3I am indebted to Joseph Sircar for his work refining this permeability protocol and collecting the
data presented here.
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Figure 3.9: Experimental apparatus for permeability experiments. The column
height h is adjustable, to provide permeability measurements at a range of head
pressures. Permeability is calculated according to Equation 2.14, where Q˙ is
measured as volume change in the syringe over time.
Figure 3.10: Summary of permeability measurements. The permeability could
not be determined for the coarsest clots (1 mg/mL fibrinogen, 10 nM thrombin
and 0.5 mg/mL, 1 nM thrombin), because clots were not stable under the lowest
head pressures (2.7 kPa), which corresponds to a column height h = 27 cm.
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3.2.1 Applicability of effective medium theory
In Section 2.4.1 I explained that effective medium theory is useful because (1) it
can be easily tested and (2) it accounts only for hydrodynamic diffusion suppression.
If it applies, it helps clarify the relevant phenomena governing nanoparticle transport
in fibrin. Figure 3.11 shows that the data are in agreement with the effective medium
theory, which predicts Deff as a function of a medium’s Darcy constant κ and a particle
diameter d. Note that this agreement does not rely on fitting parameters: κ, Deff , and




















Figure 3.11: Left: My data (dots) for Deff (from Figure 3.6) and κ (from Fig-
ure 3.10 validate the effective medium theory (lines). Diffusion and permeability
were measured on clots made from 1 and 3 mg/mL fibrinogen with 10 nM throm-
bin, and 1 mg/mL fibrin with 5, 10, and 30 nM thrombin. Bars are 95% confidence
intervals. Right: Results showing poor agreement between data and the effective
medium theory (dashed line, labeled “eqn. 2”) in agarose gels (Johnson et al.,
1996). The theory that shows better agreement (solid line, labeled Eq. 3) uses
Equation 2.13, but uses Equation 2.25 in place of F . The need for a steric term is
not because the relative sizes of particles and fibers were different, but because
the timescale of the measurement was too long.
My validation of the theory here contradicts the results of prior work in agarose
gels (Johnson et al., 1996). In that study, the particles were 4–12 nm in diameter
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and the inter-fiber spacing of the gels was roughly 4–11 nm, using their estimation of
R =
√
κ/2. In some cases, then, the relative sizes of particles and mesh size are similar
to those of my results in fibrin (with, say, 500 nm particles and 1–5 µm fiber spacing).
Yet their measurements show that the effective medium theory predicts 20–30% higher
values for Deff/D0. The reason is that their diffusion measurement occurred over 20 µm,
a distance over which a particle in agarose would have passed thousands of strands.
Therefore, the measurement was clearly taken for longer than the steric-τ , or in region
III of Figure 2.5.
Figure 3.12 clarifies this distinction for diffusion measurements in an arbitrary fi-
brous gel. I have scaled the axes by the length and timescales of the diffusion measure-
ment, so that the steric effect should begin at position (1, 1). To place the fibrin experi-
ments of this work and the agarose experiments of Johnson et. al. in the context of this
Figure, consider that for fibrin that τstartup ∼ 10 s (as suggested by Figure 3.8), and my
diffusion measurements were taken below τ = 1 s, so τ/τsteric ∼ 1/20—clearly in the hy-
drodynamic regime. By contrast, the agarose data have 〈r2〉/R2 ∼ 20 µm/(10 nm)2 ∼ 106—
clearly in the steric regime.
3.2.2 Measuring permeability with effective medium theory
It is convenient that the effective medium model applies to fibrin, because a high
throughput diffusion assay could measure clot permeability. However, there is an appar-
ent difficulty: according to Equation 2.25, Deff is determined both by the gel (through
κ) and the viscosity and temperature of the solvent (through D0). In clots—particularly
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Figure 3.12: A scaled version of Figure 2.5 that clarifies this distinction for dif-
fusion measurements in an arbitrary fibrous gel. I have scaled the y-axis by the
length-scale of steric interactions R2, and the x-axis by the timescale of steric in-
teractions τsteric, so that the steric effect should begin at position (1, 1). Critically,
diffusion cannot be related to permeability in the steric region without knowing
detailed gel structure (namely, φ and df), while in the hydrodynamic-only regime,
the effective medium theory can be used for this purpose.
those of plasma or whole blood—the solvent is not well controlled, and may vary sub-
stantially from the viscosity of water. In fact, a higher viscosity is expected in PPP; aD0
roughly 30% lower than that in water has been measured in PPP (Kirschenbaum et al.,
2000), and the viscosity of blood is 2- to 100-fold ηH20 (Rand et al., 1964). Conceivably,
this viscosity could be measured by eluting the solvent from the clot and measuring its
viscosity independently, but this would be impractical in a high throughput protocol.














This normalizes away η0, relieving the need to independently determine the solvent
viscosity at the cost of a second, nearly identical diffusion measurement in each type
of clot.
I can follow this prescription with the data above to find the ratio Dd1/Dd2 in
each clot type. The data show satisfying agreement with the theory, as shown in
Figure 3.13. However, the sensitivity of this measurement is not good: small variations
in D200 nm/D500 nm result in sharp changes in κ. The sensitivity of this technique
(essentially, the slope of the solid line in Figure 3.13) depends critically on the sizes
of the particles relative to each other and to
√
κ. For comparison, I have also plotted
D100 nm/D800 nm, which shows improved sensitivity. Unfortunately, 800 nm particles
are not commercially available.
Figure 3.13: The ratio D200 nm/D500 nm (dots) agrees well with theory (blue line)
and normalizes out D0, allowing measurement of κ when the solvent viscosity
is unknown. However, the sensitivity of this measurement is not good. The
ratio D100 nm/D800 nm (green line) shows improved sensitivity, but as particle sizes
approach 1 µm, steric effects will begin to manifest. This is cause for concern: I
have not found theories relating Deff and κ that account for steric effects without
requiring additional structural information—namely, φ or df .
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3.3 Discussion
3.3.1 Diffusion and permeability as a measurement of clot
structure
Coagulation pharmacy is imminently preoccupied with the effect on clot structure
of drugs such as low molecular weight heparin (LMWH), fondaparinux, polyphosphate,
and acetylsalicylic acid (aspirin) on clot structure (Collen et al., 2000; Varin et al., 2007;
Smith and Morrissey, 2008; He et al., 2009; Ajjan et al., 2009). This interest exists
because of clot structure’s correlation with various pathologies. However, electron or
confocal microscopy of clots is low-throughput and relatively expensive, and not easily
reduced to quantitative parameters. By comparison, free particle diffusion generates
Deff , a single-parameter indicator of clot structure.
Figure 3.6 shows that particle diffusion is correlated to clot structure over a phys-
iologically relevant range of fibrinogen and thrombin concentrations. Diffusion also
resolves structural differences in hemophilic clot structure, demonstrating that the anal-
ysis presented in this Chapter addresses physiologically relevant parameter spaces in
clotting.
Beyond these qualitative observations, can I establish a quantitative path to deter-
mine clot structure from transport measurements, thanks to the κ(φ, df ) equations of
Sections 2.2 and 2.3. Given actual measurements of Deff and κ, the models of diffusion
suppression and permeability may be solved and plotted as df (φ). Two such plots—one
for a fine clot (small df , high fiber number density), and one for a coarse clot (large df ,
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Figure 3.14: Using this Chapter’s results for Deff and κ, I have solved each model
for df (φ). The theories predicting diffusion suppression are plotted in blue; the
theories predicting permeability are plotted in red. The text argues that the
Jackson-James, Davies, and hydrodynamics-only version of the Phillips model
are correct. Note that only these three models simultaneously intersect in both
fine (top chart) and coarse (bottom chart) clots.
This Figure can help us identify which models for
Dd1
Dd2
and κ(φ) are correct. Note
that somewhere on each plot there is one point (φ0, df0) that represents the clot’s true
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values of fiber diameter and volume fraction. As shown in Figure 2.7, the models
expected to predict fibrin permeability (Jackson-James, Davies, and Carman-Kozeny
relations) are all similar to one another in the relevant ranges of φ and df . Therefore,
the true point of gel structure (φ0, df0) is expected to lie along the area swept out by
these lines.
Now consider the models treating diffusion. Because the (purely hydrodynamic)
effective medium theory holds, I do not expect the Ogston model, which is completely
steric, to be valid in fibrin. Figure 3.14 confirms this expectation: the Ogston model
either predicts extremely small fiber diameters (10–20 nm, equivalent to fibers com-
prising only one or two protofibrils), or extremely large volume fraction (5–10% for
100 nm fibers, a φ more consisent with platelet-retracted clots (Diamond, 1999)). The
Ogston model also never intersects the Davies and Jackson-James equations, which is
consistent with the Ogston Model being inaccurate in this material.
The Phillips model, on the other hand, agrees with the Davies, Jackson-James, and
Carman-Kozeny equations to within a factor of 2. Interestingly, ignoring the steric
term of the Phillips model (setting S(f) = 1) produces a function that agrees with the
κ(φ) models precisely at their location of closest approach. The intersection of these
three models provides a plausible prediction of df and φ that uses permeability and
diffusion.
This analysis raises two important questions. First, what does it mean to ignore the
steric term of the Phillips model, and is this justified? Second, what is the justification
for finding fiber diameter and volume fraction in this way, when for decades imaging
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has been used for the same purpose?
To the first question, steric effects will manifest only if diffusion is measured over
timescales long enough to see particle collisions with the gel. Generally speaking, the
long-time diffusion of Figure 3.8 shows no variation in diffusion coefficient as a function
of τ , however, in the denser clots there is a gradual transition to a lower α for some
of the particles. Physical barriers that knock the particle backward (or prevent it from
advancing) can create such “sub-diffusive” behavior in 〈r2〉 curves. In these short-time
(< 10 s) experiments, therefore, steric effects do not manifest. Using the language
of Section 2.1.3, the transition τ to steric diffusion suppression is ∼ 1–10 s in high-
fibrinogen clots. This result is consistent with the analysis of that Section.
In a lab of infinite resources, the answer to the second question is to do all the
measurements. However, should resources be constrained, the technique presented
above offers two advantages. Permeability, measured directly or with the prescription
of Section 3.2.2, speaks specifically to issues of clot stability. Second, the diffusion and
permeability can be measured to arbitrary precision by increasing the volume sampled
and decreasing the head pressure, respectively. By contrast, confocal imaging has
fundamental precision limitations due to the diffraction limit, and electron microscopy
introduces uncertainty due to the required preparation. Therefore, the structure-from-
transport method potentially offers greater precision than structure-from-imaging.
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3.3.2 Diffusion as a guide for drug design
The results of this work offer insight into the desirable size range of fibrinolytic drugs,
particularly with respect to the risk of hemorrhage. There is evidence that single-bolus
fibrinolytics have advantages for early-response treatment of thrombosis, but a key risk
in such treatment is lysis of hemostatic clots and intracranial hemorrhage (Llevadot,
2001; Giugliano et al., 2001).
The relevance of this work to drug delivery is somewhat subtle. Diffusion is rarely
the primary mode of particle transport in an occlusive thrombus. Indeed, in all but
the lowest-pressure venous clots, advection dominates fibrinolytic transport into an
occlusive thrombus (Diamond and Anand, 1993). However, radial diffusion mediates
dismantling of a non-occluding clot (Blinc and Francis, 1996). Furthermore, clots are
apparently more dense near the cell surface (Wolberg and Campbell, 2008).
Therefore, there may exist an opportunity to design a nanoparticle fibrinolytic suf-
ficiently small that it efficiently advects through clots, yet sufficiently large that its
diffusion is hindered, as shown in the cartoon of Figure 3.15. I hypothesize that such
a drug would be subject to advection through an occlusive thrombus, where it would
hasten lysis and the restoration of blood flow, yet would be hindered in its lateral
transport, reducing fibrinolytic activity and therefore the risk of hemorrhaging. Fig-
ure 3.6 suggests that particles as small as 200 nm are within the critical size range to
exhibit suppressed diffusion. In denser environments, such as platelet-retracted clots,
this range may begin at smaller size.
To operate in this fashion, a drug must advect efficiently, and I have not explicitly
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Figure 3.15: Concept for a diffusion-hindered fibrinolytic drug vector near a
vessel boundary. An ideal particle would be large enough that its diffusion was
hindered, yet small enough that it was not lodged in the fiber matrix, so that fluid
flow could drive it down the vessel. This setup would be conducive to destroying
occlusive clots, but leaving hemostatic clots intact.
measured advective transport of PEG particles in fibrin. Also, the static PEG particles
merit further investigation, as the mechanism that prevents their diffusion is unclear.




The preceding chapters explore the relationship between transport through and
structure of fibrin gels. Those results have implications for clinical and research mea-
surements of fibrin and plasma clots. Yet they also raise questions about the local
environment experienced by the particles. In this chapter I will discuss additional ex-
periments that help clarify the particles’ local physical environment. In particular, I
explore the force required to pull stuck particles free, and I determine whether the
particles’ mechanical environment carries information about the bulk elasticity of the
gel.
4.1 Stuck particles
How stuck are the stuck particles—or, what force is required to pull them free?
This is a key question for issues of drug delivery, as mentioned in Chapter 3. The
relevant force range is determined by physiology, particularly by whether the flow of
blood would exert sufficient force to avoid association of the particle with the gels.
I have used a Multiforce High Throughput System (Spero et al., 2008) to force
PEG-coated magnetic particles through the gel. The experiment is summarized in
Figure 4.1. Briefly, clots of fibrinogen concentrations 0.5–3 mg/mL were prepared
(see Section 3.1), and plated into a magnetic microplate using the protocol of the
above reference. Super-paramagnetic 2.8 µm particles with both PEG and carboxylate
(COOH) surface chemistry were subjected to three force pulses that lasted 3 s each.
Figure 4.1: Top: experimental protocol for magnetic manipulation of 2.8 µm
particles. Clot types tested were 0.5, 1, and 3 mg/mL fibrinogen with 10 nM
thrombin. Bottom left: time lapse (minimum intensity projection) image of
a typical PEG particle pulling experiment. Some particles oscillate back and
forth (green ovals) while others jump long distances through the mesh, often
coming into the field of view from far away. Bottom middle: particle tracking
is performed with CISMM Video Spot Tracker except where otherwise noted.
Scale bar in video image is 20 µm. Bottom right: radial displacement, r(t), is
shown plotted for two particles in fibrin. The quantity ∆r, used in the section on
fibrin elasticity, comes from the particle recovery after the magnets are turned
off.
The motion of PEG and COOH particles is plotted in Figure 4.2. Because COOH
particles stick to fibrin, they oscillate back and forth as the force is turned on and off,
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but ultimately travel short distances (0–26 µm). Some PEG particles, by contrast,
can jump through the matrix of the gel, traveling more than 65 µm in even the least
permeable clots. Many PEG particles traveled all the way across the field of view to
collide with the pole tip. Due to the erratic motion of the pulls, videos were decimated
from 120 Hz to 4 Hz so that I could hand-track them using ImageJ.































































Figure 4.2: Particle trajectories r(t) for PEG (blue) and COOH (red) particles
in clots of increasing fibrinogen concentration: 0.5 mg/mL (left), 1 mg/mL (middle),
and 3 mg/mL (right). All clots were formed with 10 nM thrombin. Magnets were
degaussed, then pulsed three times (on for 1.5 s, off for 1.5 s). PEG particles
clearly move farther than COOH particles, frequently jumping through the mesh.
Many PEG particle tracks end early because the particles collide with the pole tip.
Due to the erratic motion of the pulls, videos were decimated from 120 frames/s
to 4 frames/s then hand-tracked. Therefore, the resolution is severely degraded,
and pulls from different videos do not cleanly align with one another.
The net travel of PEG particles as compared with COOH particles are shown in
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shown in Figure 4.3. The mean distances traveled by PEG particles as reported in
Figure 4.3 are lower bounds, because 31% (fine clots) to 44% (coarse clots) of particles
entered the field of view from offscreen while the forces were being applied. By contrast,
no COOH particles enter the field of view during the pulling except in the coarsest clots,
in which 11% of particles entered from offscreen. The force applied to particles at the
pole tip was 2 nN; at the edge of the field of view (∼ 150 µm from the pole tip) the
force was 0.1 nN; the force exerted on particles offscreen was less than 100 pN.






















Figure 4.3: Net displacement of 2.8 µm PEG particles (dots) and COOH particles
(circles) after three pulses of 1 second each. Points show mean displacement; bars
show minimum and maximum displacement. Number of COOH particles N = 9,
10, 11 and number of PEG particles N = 39, 10, 13 for 0.5, 1, and 3 mg/mL
fibrinogen, respectively.
The heterogeneity of particle environments is responsible for the broad range of
particle motion in Figure 4.3: some particles are easy to pull free, others are not.
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However, large forces were not always required—indeed, the particles that traveled
furthest started the greatest distance from the pole tip, and therefore experienced
the smallest force. Forces < 100 pN (the force at the edge of the field of view) are
adequate to drive PEGylated 2.8 µm particles long distances in these gels. A particle
in water experiences this force at a flow rate of v < 4 cm/s. The higher viscosity
of blood would further reduce the required flow rate. Arterial flow rates are about
75–110 mL/min (Knaapen et al., 2009), which for a typical artery lumen diameter of
4 mm (Dodge et al., 1992) corresponds to a fluid velocity of 10–15 cm/s. This result
suggests that whatever the reason for the association between stuck PEG particles and
fibrin, freely flowing blood may be able to prevent it from developing.
At this stage the mechanism of particle sticking remains unknown. However, I can
speculate on the responsible phenomena. The moderate forces required to pull stuck
PEG particles free suggests that there are no strong chemical associations between the
particles and the fibrin. The entrapment may be purely mechanical, with particles
captured among strands of fibrin. Physical entrapment is consistent with the result
that larger particles diffuse less.
Particles might also stick to fibrin fibers because of depletion flocculation, an en-
tropic effect where small solutes cause large colloids to aggregate. Depletion flocculation
has been proposed as a mechanism for lateral aggregation of fibrin fibers (Gelder et al.,
1996). Also, the higher concentration of macromolecules in PPP clots (the same ones
responsible for raising plasma’s background viscosity) could act as a crowding agent,
explaining the observation that the percentage of static particles was higher in plasma
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clots than in purified gels.
4.2 Fibrin elasticity
Although this dissertation has focused primarily on transport, fibrin elasticity is also
an important clot property. Clots form an essentially mechanical function—stemming
the flow of blood—and it is well established that clot stiffness varies with clot struc-
ture (Ryan et al., 1999) and with risk of heart disease (Fatah et al., 1996). Clot
rheometry is even used as a clinical diagnostic, in a cup-and-bob geometry often called
thromboelastography (Evans et al., 2008).
The systems of Chapter 5 are well designed for high throughput characterization
of fibrin clot stiffness. From Mason and Weitz (Mason and Weitz, 1995) to Crocker
et al (Crocker et al., 2000) to Meehan and Cribb (Meehan et al., 2010), much work
has been done to identify conditions under which the bulk viscoelastic properties of
polymer media can be measured by nanoparticles. Magnetic microbead rheometry has
even been used to measure clot stiffness during gel formation (Ajjan et al., 2008). Yet
it remains unknown whether micro-scale techniques measure the same elastic modulus
of fibrin as conventional macro-scale techniques such as cone-and-plate (CAP).
I have checked for this correspondence by comparing the data from Section 4.1
against cone-and-plate (CAP) results. To extract a storage modulus from the r(t)
results discussed above, I calculated J(t) = 3pidr(t)/F (Ziemann et al., 1994). The
data are plotted against strain, defined for driven micro-rheometry as γ = 3∆rd (Cribb,
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2010). To measure bulk G, clots were similarly prepared, except in 300 µL volumes,
then loaded into a rheometer with a 1◦ cone. Recovery compliance was measured at
four different initial strains. The results of both CAP and MHTS measurements are
shown in Figure 4.4.
Figure 4.4 indicates that microrheometry does not measure bulk fibrin elasticity,
because the MHTS data do not overlap the CAP results. For MHTS measurements
(dots), I subjected particles in all three types of clots to a fixed range of forces, so the
strain is greater in clots of low fibrinogen concentration. As fibrinogen concentration
increases, the strain reduces, while the measured stiffness increases. Because the CAP
can be operated in a strain-controlled fashion, those results (lines) show strain stiffening,
a well-established characteristic of fibrin gels (Janmey et al., 1983). Higher strain
measurements were not feasible in this geometry, because the gel pulled loose from the
rheometer plate. At all concentrations, magnetic microrheometry under-predicts the
bulk storage modulus.
The reason for this disagreement would seem to be that the particles are not large
enough. In the limit of a very large (say, 1 cm) particle, one would expect complete
agreement with macroscopic data, because, barring some unanticipated anisotropy, an
applied stress of any geometry at a length scale comparable to that of the CAP should
measure similar mechanical properties. By contrast, to judge from the confocals of
Figure 2.2, a 2.8 µm particle could potentially be touching only one fiber at a time. In
this situation, one would expect the micro-rheometry measurement to be lower than
the bulk measurement, because the act of pulling on one fiber would be analagous to
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pulling on a single spring, while the act of pulling on the whole gel would be analo-
gous to pulling on many springs in parallel; the latter case represents a stiffer material.
If this hypothesis is correct, particles larger than the mesh size of the material—say,
> 10 µm—should measure bulk viscoelastic properties of fibrin. (Unfortunately, par-
ticles of sufficient magnetic loading are not available in that size.) In fact, the required
size is somewhat larger; the reason for this is left to the detailed discussion of Sec-
tion 5.4.2.
Figure 4.4: Storage modulus, measured by cone-and-plate (lines) and driven
4.5µm particles in the MHTS (circles). Clot types were 0.5 mg/mL (blue),
1 mg/mL (red), and 3 mg/mL (green) fibrinogen mixed with 10 nM thrombin.
Figure 4.4 does confirm that the MHTS can resolve the differences in elasticity
among the three clot types, demonstrating its potential as a high throughput platform
for evaluating the mechanical properties of clots. The measurement can be performed
during the formation of the clot, producing a stiffness vs. time curve, shown in Fig-
ure 4.5 that may be adequate as a high-throughput counterpart to the clinically tested
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technique of thromboelastography. However, additional work remains to develop this
assay. The fact that G continues to rise after the clot finishes forming (Figure 3.5 shows
that polymerization for this type of clot finishes in under 20 minutes) suggests that the
measurement is altering the gel, perhaps dragging the particle forward, piling material
in front of it. Examination of the full “tuning fork” profile of G(t)—in which plasma
is allowed to move through the whole process of clot formation and lysis—will be an
additional step in developing this technique.
Figure 4.5: Storage modulus in 1 mg/mL fibrinogen, 10 nM thrombin measured
over the course of the gel formation. The fact that G continues to rise after the
clot finishes forming suggests that the measurement is not adequately developed;
perhaps the particle is being dragged forward.
73
4.3 Future Directions
The diffusion and magnetic microrheometry measurements made in this dissertation
have elucidated some of the specific phenomena relevant to particle transport in clots.
It has also opened new areas for inquiry, particularly regarding the dynamics of stuck
particles and the design of drug delivery vectors.
A new platform is required to fully characterize particle adhesion for vascular drug
delivery, one that can simultaneously measure clot permeability, particle diffusion, and
clot structure. A platform that better captures the geometry of a blood vessel is
also desirable. Figure 4.6 presents a flowcell concept drawing that addresses these
needs. The design of this device offers several benefits over a traditional permeability
measurement. First, it is flow-controlled, meaning it can measure permeability at a
much wider range of flow rates than practically achievable by gravity-driven (pressure-
controlled) flow. Second, it provides a “four-point” measurement of flow resistance
(analogous to the traditional four-point electronics measurement), eliminating errors
due to the resistance of the rest of the flow system. Third, the system is compatible
with high-NA microscopy, allowing permeability to be determined simultaneously with
clot structure, fiber deformation under flow, and particle diffusion and advection.
4.4 Conclusions
Chapter 3 demonstrated that the local environment of nano-particles in fibrin ap-
pears to be purely hydrodynamic for freely diffusing nanoparticles. In this Chapter I
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Figure 4.6: Schematic of a flowcell for measuring diffusion, particle-fibrin dynam-
ics, and permeability. A syringe pump controls Q˙, forcing a fluid with viscosity
η through a clot with dimensions A×L and unknown permeability κ. The differ-
ential pressure gauge supplies ∆P , which provides the final required quantity to
calculate κ from Equation 2.14. Using a microfluidic chamber for the clot permits
high-NA microscopy of particles inside the clot.
demonstrated that larger (micro-scale) PEG-functionalized particles, though immobile,
appear to be only loosely associated with the gel, suggesting that gravity, depletion in-
teraction, or very weak chemical interactions are responsible for the existence of stuck
particles.
I have also compared the elastic modulus of fibrin at the micro and macro length
scales. Because micro-sized particles are on the order of, or smaller than the spacing
between fibers, driven microrheology in the MHTS does not measure the bulk elasticity
of the gel. However, the measurement does reveal the time-dependent stiffening of the
gel during clot formation, and may therefore serve as a high throughput, small specimen




My results have implications for coagulation research and drug design. But these
experiments’ long-term utility will be determined as much by the operational difficulty
of making the measurement as by the scientific questions at hand. In this Chapter I
present novel instrumentation for high-throughput characterization of clot transport
and mechanics. These systems are a high throughput “multiscope” and a microplate-
based force application system for biophysical experiments.
Biophysical experiments include more than diffusion and driven microrheology of
fibrin. The systems presented in this Chapter are designed to accelerate data acqui-
sition and processing for a wide range of measurements, including passive and driven
microrheology of fibrin, mucus, DNA, extracellular matrix, and other polymers; sin-
gle cell mechanics; cell migration and cytometry; and cell-substrate interaction using
microscale post arrays.
Transitioning any of these experiments to high throughput would require automated
microscopy, commonly called high content screening (HCS). The essential task in this
growing field is to take more images, faster, with less human intervention. The benefits
are evident in the wide range of results being acquired with HCS systems. These include
results on the proteins (Shen et al., 2006) and genes (Simpson et al., 2008) involved in
cell migration. Recent work used siRNA knockdown to identify every gene relevant to
cell division (Neumann et al., 2010). High content cell screening is increasingly critical
for drug discovery (Lang et al., 2006).
The benefit of an HCS system for the experiments in this dissertation are also
apparent. The fibrin diffusion experiments of Chapter 3 used 10 minutes of video per
specimen, assuming five videos per clot and two clots per preparation. The total from
eight specimens and two bead sizes—using 32 wells in a microplate—is nearly three
hours of video. Yet eight specimens is a tiny fraction of the parameter space we would
ideally hope to explore. Consider the human genome siRNA study of genes involved in
cell division, and consider a similar knockdown of the genes involved in clot formation
above cells, using recent experiments (Wolberg and Campbell, 2008) as a template.
One diffusion measurement would be required to test each gene (roughly 21,000) at
each particle size (at least 2), against a range of clot types (perhaps 4 donors’ worth
of healthy plasma). This experiment alone represents 420 mL of plasma per donor
(assuming 20 µL of plasma per well), and 168,000 measurements of Deff . At 10 minutes
of video per measurement, the experiment would last 28,000 hours, or 3.2 years, running
day and night. Clearly, an automated, highly parallel system would be required.
While HCS has improved throughput for cell imaging, it has left microrheology
behind. This is unfortunate, as microrheology shows promise as a tool for scientific
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and industrial high throughput screening (Breedveld and Pine, 2003). However, the
specifications for a microrheology instrument are different in key ways. First, high
bandwidth video is desirable to capture dynamic phenomena. Second, the specimens
are not planar, because the particles are distributed through the material volume.
These specifications are not met by the various commercial HCS systems for imag-
ing cytometry. The manufacturers (Beckman Coulter, GE, Perkin Elmer, Roche, and
Thermo) provide software designed for snapshots, rather than high framerate (> 10 Hz)
video microscopy. Their autofocus routines are designed to identify planar specimens.
Their image processing software typically excels at cytometry (measuring cell area, cir-
cularity, migration), but lacks high-precision, automated particle tracking capability.
These design decisions make existing HCS systems impractical for microrheology.
These systems’ hardware designs also place limitations on experiments—both in cell
imaging and microrheology—that are undesirable. They are not compatible (in hard-
ware or software) with force application systems, including our magnetic microplate-
based design (Spero et al., 2008). Also, the systems are all essentially a traditional
microscope over which the specimen is systematically translated. Therefore, the length
of an experiment in such a system can never be shorter than the product Nti, where
N is the number of specimens and ti is the time to acquire data from each specimen.
In addition, the single-microscope design is incompatible with simultaneously imag-
ing multiple wells, which may be desirable for recording dynamic phenomena such as
time-dependent microrheology or cell migration; even if simultaneous imaging is not
required, for any non-stationary process, the maximum sample rate is 1/Nti.
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To address these issues, I have collaborated with a team of scientists and engi-
neers to design, develop, and qualify a microscope with multiple objectives that is also
compatible with the MHTS. A “multiscope,” using m objectives, could shorten the
experiment time to Nti/m, and increase the specimen sampling rate to m/Nti. With
m = 12, the high throughput clotting experiment mentioned above, for example, would
collapse from 3.2 years to 97 days, or about 3.3 months. The name of this multiscope
project is “Panoptes,” after the never-sleeping, hundred-eyed god of Greek myth (Rose,
2001).
5.1 Panoptes: High Throughput Video Acquisition
Panoptes is envisioned as an array of microscopes, each fitting within a 1.8x2.8 cm
footprint, allowing simultaneous imaging of up to 12 wells in a standard 96-specimen
microplate. It is designed primarily to collect data for three client experiments: nano-
and micro-particle diffusion (as in Chapter 3), image cytometry, and driven particle
rheology in the MHTS (as in Chapter 4 and discussed in Section 5.3).
These experiments define Panoptes’s critical functionality:
1. Ability to resolve cells and nuclei. Image quality above this threshold is desirable.
2. Transmission brightfield and one or more channel of widefield epifluorescence.
3. Adequate signal-to-noise for client experiments, discussed in Section 5.1.3
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5.1.1 Image quality: NA and z-focus
The quality of Panoptes’ objectives will define the maximum potential imaging
quality of the system. Numerical aperture (NA) is the parameter that defines the
fundamental limit of a system’s optical resolution; inexpensive objectives (< $500)
with an NA above 0.7 are widely available. Unfortunately, higher NA also means a
tighter depth-of-field, and as a result, greater sensitivity to tilt or curvature in the well
plate. Therefore, we desire independent focus control for each microscope.
The traditional approach to z-focus is to mechanically translate the objective. While
micro-manipulators of sufficient precision exist, they are expensive, starting at > $500,
even before placing serious constraints on slew rate, backlash, mechanical smoothness,
or package size. This coupled with our desire for high NA (and tight depth-of-field)
would lead to a slow auto-focusing routine. Indeed, autofocus speed is well established
in the field as a limiting parameter for experiment throughput. The speed is determined
by both the algorithm and the time required to collect the data. The algorithm may
be accelerated by creating a dedicated auto-focusing circuit (Bravo-Zanoguera et al.,
1998), but this is costly and reduces the variety of algorithms (or autofocus targets)
supported. Image acquisition time is limited by the required light collection, which is
minimized when imaging in a bright mode such as phase contrast (Price and Gough,
1994). Image acquisition can also be accelerated by enabling continuous scanning dur-
ing image acquisition (Bravo-Zanoguera et al., 2007). However, quantifying the speed
of auto-focus alone can be distracting. The ultimate metric of throughput is the number
of datapoints collected per unit time: for example, image cytometry is often quantified
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in cells imaged per hour. The state of the art for image cytometry systems is cur-
rently 100–1,000 cells per second, depending on the resolution and magnification of the
system (Varga et al., 2009).
In Panoptes, we are pursuing a novel z-focus strategy. We have employed an elec-
trowettable liquid lens (Hendriks et al., 2005). This technology uses immiscible fluids
of different refractive indices, contained in a chamber whose wet-ability varies with
voltage, to form an electronically controllable lens. The only commercially available
liquid lens is the Varioptic Arctic 416. I am indebted to L. Vicci for her work mounting
a Varioptic lens inside of an off-the-shelf 40x, NA 0.7 objective, creating an objective
with electronic control of the object plane. The lens has a fast focusing response time
(< 100 ms peak-to-peak), varies focus from 0–350 µm into water, and is mechanically
silent. However, the Varioptic lens is NA-limiting, as its 2.4 mm aperture is the small-
est in the optical system. This begs the question: why sacrifice NA for a focusing
technology that was supposed to support high NA microscopy?
I offer two reasons. First, the Varioptic lens allows faster focusing than any other
strategy. While the peak-to-peak response is 100 ms, the bandwidth of the control
signal is about 10 ms, so for small voltage changes, the z-response may be much faster,
suggesting we may be able to refocus the objective between successive frames. In this
case, the data-stream for the autofocusing algorithm could be 3-dimensional, allowing
algorithms that find parameters of whole image stacks, rather than individual slices
(e.g., net image intensity or the standard deviation of the intensity distribution). Such
stack-based autofocus might be more computationally efficient than existing algorithms.
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Second, the liquid lenses are a young technology. It is plausible that larger aperture
lenses will become available over time. It is a strategic decision to develop Panoptes
around the assumption of a voltage-controlled z-focus, with the expectation that im-
proved imaging will become feasible in the future. Indeed, a larger aperture liquid lens
is sufficiently desirable that future development plans could include designing such a
component in-house.
I must also stress two important caveats in the use of a tunable lens element. First,
the liquid surface used for lensing is spherical; this necessarily introduces spherical
aberration as the lens power increases. The only way to correct this aberration is with
other tunable lenses, leading to a custom-designed objective of tunable lens elements.
Second, changing the objective’s focal length1 without adjusting its tube length2 will
lead to a change in magnification3. The solution to this issue is to build a look-up table
for magnification as a function of lens state.
5.1.2 Imaging modes: brightfield and fluorescence
Fluorescence is used as a marker of gene expression or cell function. It also provides
the highest-contrast mode to image sub-micron particles in experiments such as those
of Chapter 3. Brightfield illumination proves ideal for experiments involving magnetics
and particles where d > 1 µm, as it is provides high contrast images of the pole tip and
magnetic particles. Furthermore, brightfield is not light-limited, making it the prefered
1focal length: distance between the objective and the specimen plane
2tube length: distance between the objective and camera
3Magnification: ratio of object distance to image distance, M = zo/zi
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choice for capturing high-bandwidth phenomena. In this Section I discuss the design
and validation of Panoptes’s fluorescence and brightfield optical trains4.
Figure 5.1 shows Panoptes’s optical path, which provides Kho¨ler illumination for
both transmission brightfield and single-channel epifluorescence. All components of
this optical train are small enough to be arrayed in a multiscope system. A detailed
bill of materials is provided in Appendix B.
Figure 5.1: Panoptes optical path. The system supports transmission brightfield
and epifluorescence.
4I am indebted to Jeffery Cohen, who contributed to the work of this Section
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5.1.2.1 Single-channel widefield epifluorescence design
For epifluorescence, the condenser lens is also the imaging objective, and therefore
the back focal plane is not usually known. However, an image at a lens’s back focal
plane corresponds to a conjugate image at infinity in front of the lens. Therefore, we can
conveniently verify that we have achieved Kho¨ler illumination by projecting the image
of the LED onto a screen placed at the objective’s far-field. The optimal collector lens
selection and position would ensure that the image of the LED at the objective’s back
focal plane is small enough to fit within the Varioptic lens aperture, and that the solid
angle collected from the LED captures as much light as possible.
Figure 5.2 helps clarify which adjustments can be made to optimize the fluorescence
illumination. Consider the objective location to be fixed. It is best to keep the collector
lens close to the objective, to minimize the magnification of the LED; the minimum
separation is set by the physical size of the objective and the need to place a dichroic
between these two elements. Reducing the collector lens aperture can improve con-
trast by reducing the illumination intensity above and below the imaging plane while
preserving the illumination intensity across the field of view. However, the smaller the
aperture, the smaller the solid angle collected from the LED, which reduces the overall
intensity and therefore the overall signal. The LED is moved into the correct position
behind the collector to achieve a focus at infinity on the far side of the objective.
To obtain the best possible illumination field, a small aperture, short focal length
collector lens is desirable, allowing minimum separation between the LED, collector,
and the objective. This maximizes contrast, maximizes the captured solid angle of
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Figure 5.2: Top left: optics schematic for Panotes’s epifluorescence illumination
train. Bottom left: Results for contrast measurements of fluorescent particles.
Reducing the collector lens aperture improves the contrast of the fluorescence
signal by decreasing the illumination field, and the imaging quality is far superior
when all fluorescence filters are installed. Right: Sample images showing regions
where min, max, and average pixel values were calculated.
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light from the LED, and minimizes overfilling of the back-aperture of the objective.
Currently, we are using an LED with an emitting diameter of 0.5 mm and half-cone
angle emission of 80◦, and a collector lens with an aperture of 15 mm and a focal length
f of 12 mm. To measure the contrast of this illumination arrangement, line scans of
200 and 500 nm particles were compared with and without a 4 mm aperture in front
of the collector lens. The data are shown in Figure 5.2. As anticipated, reducing the
collector lens aperture improves the contrast, at the expense of the total fluorescence
signal. In the next build of Panoptes, we will have a custom-cut dichroic that will allow
a shorter total optical path, and permit us to capture more solid angle from the LED,
while still improving image contrast.
5.1.2.2 Brightfield design
For brightfield, the condenser lens must focus light through the MHTS magnetics
block, which places a lower bound on its focal length (16 mm) and, thanks to the 1/8”
annulus, an upper bound on its NA (0.21). The images shown below use 1” optics; we
have deferred selection of final illumination optics until after the construction of the
inverted microscope. However, a wide range of LEDs and inexpensive, injection-molded
lenses are available.
We have chosen to not pursue phase contrast microscopy in this design, but I will
note that an interference imaging mode would be a minor modification to this design.
The traditional phase contrast microscope uses an amplitude mask on the illumination
side and a phase mask behind the imaging objective; newer approaches use so-called
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“common-path” interference, where all the phase filtering is handled entirely behind the
objective (Glu¨ckstad and Palima, 2009). The latter approach is recommended in this
application for two reasons. First, it relies on NA= 0 illumination, which is convenient,
given the low-NA limit placed by the MHTS block. Second, the phase arrangement
can be placed entirely behind the microscope camera, increasing design flexibility, and
suggesting a modular approach where phase filtering need not always be applied.
5.1.3 Image quality and particle tracking signal-to-noise
It is a natural first step to qualitatively evaluate the imaging of familiar specimens.
Figure 5.3 shows ovarian cancer cells in both brightfield and fluorescence. The cells’
and particles’ locations and shapes can be easily identified. Fluorescence appears to
provide better contrast but less detail, particularly in the interior of the cells.
In its envisioned operating modes, however, Panoptes’s video output will be viewed
rarely. More common will be the extraction of particle trajectories from the video.
The quantity 〈r2〉 of particles on a rigid substrate is the noise floor for diffusion ex-
periment and provides insight into the tracking resolution. Figure 5.4 shows the noise
floor measured for particles on glass, with a flat, or non-scattering background. It is
important to note that particles viewed over cells, through mucus, or in other scattering
environments would have a higher noise floor.
Fluorescence is particularly useful for minimizing the noise from scattering environ-
ments. For this reason, I take the fluorescence noise floor as the standard by which
to measure Panoptes’s promise for particle tracking. Figure 5.4 compares these noise
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Figure 5.3: Mitotracker red-stained ovarian cancer cells with 2.8 µm magnetic
particles in Panoptes. The cells’ and particles’ locations and shapes can be easily
identified. The particles are clearly differentiable from the cells in brightfield,
but not fluorescence. Some cell texture is adequately resolved, including the






















500nm bead in dense fibrin
HBE Healthy (2.5%)
HBE Thick (5.8%) − lower bound
R3 cell diffusion
NOSE cell diffusion
Figure 5.4: Panoptes noise characterization. The brightfield line (magenta)
suggests ability to resolve 20 nm excursions; the fluorescence line (red) sug-
gests the ability to measure 50 nm excursions. These noise floors are valid at
10 ms < τ < 10 s.
88
floors with three types of diffusion experiments: the fibrin diffusion experiments of
Chapter 2, passive mucus microrheology, and diffusion of particles on cells. Fibrin
experiments clearly avoid the noise floor, implying that if Panoptes can see 500 nm
particles, then the particles can be accurately tracked. CF-like (5.8% solids pig gas-
trine) mucus can be below the fluorescence noise floor until τ = 10 s; therefore, long
data acquisition times at low framerate (∼ 10 minutes) are required to get good statis-
tics (two decades beyond the τ used) for the calculation of 〈r2〉. Cell diffusion is clearly
below Panoptes’s tracking resolution.
Figure 5.4 provides insight into other potential experiments. The noise floor of
〈r2〉 = 10−14.3 m2 implies typical excursions ∼ 100 nm. This helps identify whether
Panoptes can be used for experiments in addition to diffusion. For example, typical cell
compliance and fibrin elasticity measurements involve particle excursions of > 100 nm,
indicating a signal-to-noise of at least 2 for fluorescence imaging. The signal-to-noise of
mucus viscometry, by contrast, is limited primarily by data acquisition time, because
pulling longer will always make the particles move farther. Figure 5.5 summarizes these
observations, along with signal-to-noise values for diffusion experiments.
The Panoptes prototype enables a fully high throughput diffusion experiment. I
have used this optics train, along with control software developed by R. Schubert, to
automatically acquire diffusion data from plated fibrin clots. Automation relieves the
technician of book-keeping burdens, so acquiring data in more fields of view for shorter
periods of time becomes the preferred strategy. For example, 15 seconds of video in
10 fields of view might be captured in each well. If two wells are used for each type of
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Figure 5.5: Experiment checklist. Required specifications and Panoptes’s perfor-
mance are listed above. For cell pulling, the signal-to-noise ratio for brightfield is
probably optimistic, because noise floor data were taken on clear glass. Because
cells add background texture, they will likely degrade particle tracking, reducing
the noise floor. Therefore, fluorescence is likely the preferable imaging mode for
cell pulling experiments.
clot, then each type requires 2.5 minutes of data collection.
5.2 Transitioning to High Throughput Protocols
In this section, I address the data processing issues that, as with many modern ex-
periments, throttle diffusion measurements. The first task in bringing any experiment
to high throughput is to chase the bottleneck. For many modern experiments, this
bottleneck is in the data processing. For diffusion measurements, the bottleneck is par-
ticle tracking. The auto-tracking algorithm used in this work effectively eliminates that
bottleneck: though it might take 10-20 hours to track all the particles in a dataset, the
algorithm, developed by R. Schubert and R.M. Taylor II, can run without supervision,
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relieving the technician of a tremendous burden.
Relieving the bottleneck, however, creates a flood of new data. Suddenly, instead
of tens of particle traces, the technician can collect thousands. Where previously he
could review each particle trace for tracking errors, he is now constrained to review a
small percentage. Techniques to spot-check data quality become critical.
As with any automated routine, failure modes for auto-tracking are inevitable.
Through spot-checking, the technician can notice common types of “bad traces,” and
he can create filters to remove these traces from the data before analysis.
As the technician builds confidence in the data pipeline for an experiment, he will
become curious about the sensitivity of the measurement to video quality, tracking
parameters, filters, and analysis parameters. The technician’s goal will be to make his
experiment as insensitive as possible to variations in the analysis pipeline, as this is
surely one indicator of the robustness of the measurement.
In the case of fibrin diffusion, these issues are captured in the experimental work-
flow, which is charted in Figure 5.6. The central column of tasks—clot creation, data
acquisition, tracking, filtering, and analysis—are straightforward. The difficulty in cre-
ating a robust pipeline lies largely in the feedback to earlier stages of the workflow
through the sensitivity testing step.
5.2.1 Data pathologies in fibrin diffusion measurements
I now highlight specific issues regarding data quality in high throughput fibrin dif-
fusion measurements. Figure 3.2 exhibits some clear outlier traces. Figure 5.7 demon-
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Figure 5.6: Flowchart showing a workflow for preparing Deff experiments in fibrin.
strates that these are failure modes of automatic particle tracking. The most common
error is the “ghost tracker,” a bad decision of the auto-tracking algorithm to place a
tracker on nothing. Also an issue is an image-boundary effect, where the algorithm will
continue to track along one axis even though it can go no further in the other. Pop-off
is where a tracker loses the particle a frame (or two, or three) before the algorithm
deletes the tracker. The least common, but most troubling pathology is two-particle
confusion, where a tracker on a moving particle will pass close to a static particle, and
get stuck.
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Figure 5.7: Pathological 〈r2〉 and the auto-tracking errors that generate them.
Clockwise from the top-left: ghost trackers, image boundary effect, an accurately
tracked particle, two-particle confusion, and pop-off.
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There are simple measures to filter each of these outlying trace types. Ghost trackers
are typically short-lived, and filtering trackers that last less than 2 seconds appears to
eliminate all of them. Wall-effect tracking errors occur at the extreme edge of the
image, and filtering trackers that come to the image boundary eliminates all of them.
Pop-on or pop-off trackers show sharp transitions in r2 at short timescales, so filtering
for non-stationary statistics would eliminate these trackers.
I contend that this experience in developing a high throughput fibrin diffusion exper-
iment has elements universal to bringing any experiment to a high throughput format.
Equally important, every new individual who decides to perform the measurement must
go through some version of this process. Skepticism of a new measurement will flourish
naturally; its natural predator is the ability to test the sensitivity of the measure-
ment against acquisition and processing parameters. The instrumentation designers’
responsibility, above all else, is to build a user interface hostile to the prey.
5.2.2 DataBrowser
I have designed a software interface to facilitate the process of experiment devel-
opment for high throughput microrheometry. I have based the interface around the
workflow of Figure 5.6. A mock-up is shown in Figure 5.8. The leftmost column of
interface elements provides a convenient environment to browse an experiment’s videos
and associated metadata. The types of metadata used in our experiments are cata-
logued in Appendix D.
The interface’s layout conforms to the central workflow of tracking, filtering, and
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Figure 5.8: Mockup of a data processing application, DataBrowser. The layout
assumes a central workflow of tracking, filtering, and analysis. In addition, the
〈r2〉 plot in window’s inset is active, allowing, for example, quick evaluation of
whether a tracking failure is responsible for an outlying 〈r2〉 curve.
analysis. The filter and analysis functionality is modular. The catalogue of filter
modules might include filtering by trace length or minimum particle motion. Analysis
modules might include 〈r2〉 or Deff . A modular design for filtering and analysis would
make DataBrowser more flexible, and potentially position the application to address
the needs of a wide variety of high throughput microscopy experiments beyond the
scope of this dissertation.
The interface also enables the feedback loop of testing sensitivity to refine tracking
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and filtering parameters through interactive plotting. Clicking on one 〈r2〉 curve would
allow the user to quickly review the raw video from which the tracking data were
collected. If the tracking were deemed faulty, the user could add a new filter intended
to eliminate that type of tracking error and immediately see whether it eliminates the
offending data.
Similarly, a module that calculated Deff would produce a plot similar to those in
Figures 3.6, and would support clicking on an individual datapoint. This action would
highlight the applied filters and the videos that compose the final datapoint. Un-
checking a video would trigger re-plotting without including that video’s data; the user
could then observe the sensitivity of the datapoint to that video—for example, the
unchecking of a bad video might cause the error bars of the datapoint to shrink.
The DataBrowser interface is intended to be extensible to other types of experiments
we perform in our research group, and potentially to a wide range of high throughput
microscopy experiments. Discussions with other scientists have revealed potential areas
for improvement or expansion of the DataBrowser interface. These include a step in
the pipeline for image analysis or processing (presumably before particle tracking), the
ability to import simulated tracking data, and the ability to append imaging data (for
example, quantities extracted from confocal images of clots) to the metadata of a video.
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5.3 MHTS: High Throughput Manipulation
High throughput microbead rheology consists of more than diffusion measurements.
In particular, forcibly manipulating microparticles can provide a wealth of additional
information, including information about individual cell mechanics (Bausch et al., 1998)
and nonlinear polymer rheology (Meehan et al., 2010).
There has been little intersection between the high throughput trend and mechanical
study of biological systems. One high throughput nano-manipulation device, IBM’s
“Millipede” multi-tip AFM (Du¨rig et al., 2000), is a notable exception, but its primary
application has been in data storage.
Among the systems for nano-manipulation, techniques using microbeads (particles
∼ 0.1− 10µm) have been widely applied. Microbeads are used to measure mechanical
properties of cells (Hubmayr et al., 1996; Bausch et al., 1999; Fabry et al., 2001; Lele
et al., 2007; Lenormand et al., 2007). Drug delivery strategies are being developed using
magnetic micro- and nano-particles (Dobson, 2006). Transfection efficiency has been
improved using “magnetofection,” where vectors are attached to magnetic particles
that are pushed against cells by magnetic fields (Plank et al., 2003).
Among microbead techniques, the “active,” or “driven” techniques, where an exter-
nal force is applied to a bead, can measure a wider range of moduli and are generally
more flexible than the passive techniques, where the bead motion is due to thermal dif-
fusion. Driven microrheology instrumentation includes laser traps (“optical tweezers”)
and paramagnetic attraction (“magnetic tweezers”). A laser trap offers high spatial
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resolution and can be precisely calibrated (Neuman and Block, 2004). A magnetic
system can drive multiple beads simultaneously, produce higher forces at a given bead
size, and will neither heat nor otherwise interact with most biological specimens (Fisher
et al., 2006). The benefits of a driven system are apparent in this dissertation, as well,
as the results of Chapter 4 demonstrate.
In pursuit of HTS nano-manipulation, I have collaborated with a diverse team
of engineers and scientists to design, implement, and qualify a magnetics system for
microparticle manipulation that is compatible with high throughput screening stan-
dards (Spero et al., 2008). Briefly, the Magnetic High Throughput System (MHTS)
can apply forces ∼ 1pN–10nN . It is based on standard microplate geometry, and is
designed to be scalable to 96 wells. The force calibration is uniform from well to well
within a factor of two. The magnetic crosstalk among wells is < 5%. The temperature
is controllable by a fluid recirculation system, and maintains < 4◦C temperature rise
under the most pessimistic conditions. The MHTS has measured non-linear mucus
viscosity. Finally, cells have been successfully plated and their compliance has been
measured using the system.
5.3.1 MHTS Design
The present instrument, a Magnetic High Throughput System (MHTS) consists of
two components: 1) a magnetics block, which generates magnetic flux for each well, and
2) a magnetic microplate, a custom-designed high throughput tray that incorporates a
pole-flat in each specimen well. The arrangement of these components is summarized
98
in Figure 5.9. The magnetics block contains a system of drive cores and drive coils; we
report here on a 16-well prototype with a design that is scalable to 96 wells.
Figure 5.9: A cartoon of a single well’s magnetic system. The substrate is a pole-
flat affixed to glass. The quadrants on the substrate show the footprint of a 2 x
2 section of the 384-well tray. The three-legged structure is the corresponding
section of the magnetics block. A magnetic circuit begins in the drive coil (front
well), where current creates magnetic flux directed by the drive core into the
pole. Flux jumps the specimen gap (back well) to the flat, which is connected by
two return path ears (left and right wells) to the back of the coil. By changing the
etching pattern in the specimen gap (back well), the force field can be changed. A
through-hole above the specimen gap provides access for dosing of the specimen
during an experiment, and illumination for brightfield transmission microscopy.
5.3.1.1 The Magnetics Block
Generating magnetic forces requires a complete magnetics system: drive coil, drive
core, and magnetic return path. Figure 5.10 demonstrates how a complete magnetics
system can fit within the area of one Society for Biomolecular Screening (SBS) mi-
croplate well5. Each of the 16 magnetics systems includes a drive core and two ears
5The geometry of the magnetics block is the result of close collaboration with L. Vicci; I am
indebted to her for implementing this geometry in a manufacturable block.
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that provide the magnetic return path. The magnetics block also has 16 through-holes
for brightfield illumination of the wells. To direct magnetic flux to the poles, the drive
cores and ears extend past the bottom of the coils, so that when the magnetics block





Figure 5.10: Schematics and a picture of the magnetics block; compare with the
cartoon presented in Figure 5.9. A magnetic system for a single well is outlined
by dashed square in schematic view (a). A cut-away perspective view is shown
in (b). Within the area of one well in a 96-specimen microplate, the magnetics
block houses two return path ears e, an optical relief r, a drive coil well w, and
drive pole core p. Arranging the drive core on a diagonal from the specimen well
and optical relief maximizes the volume for the drive coil. Heat transfer fluid
channels c are drilled transversely to the optical paths, avoiding the coil wire
access holes a. The 16-well prototype magnetics block, is shown in (c), populated
with drive coils, and with aluminum manifolds mounted. The manifolds interface
with a heat exchanger and recirculation pump.
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5.3.1.2 Fabrication of a biocompatible magnetic microplate
While we can place the magnetics above the specimen, the poles must be built into
the HTS microplate. This constraint has three motivations. First, the force on beads
increases with the pole tip’s proximity to the specimen. Second, when using a pole-flat,
forces are applied in the plane of the pole tip, which to record bead motion must to be
parallel to the imaging plane. (For experiments requiring forces parallel to the imaging
axis, alternate pole geometries may be implemented.) Third, a magnetic microplate
can be washed and reused. It is relatively inexpensive, and so can be produced in
quantity to allow for simultaneous preparation of many different experiments.
I assembled the magnetic microplate by adhering a pole plate underneath a bottom-
less plastic 384-well superstructure (Thermo Fisher Scientific, Portsmouth NH). The
pole plate is an of array 16 pole-flats fixed to a 4.33′′x2.93′′ #1-thickness coverglass. I
summarize the process in Figure 5.11.
Figure 5.11: Magnetic microplate fabrication.
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We use a commercial photolithographic etching process (Fotofab Corporation, Chicago
IL) to manufacture the pole plate pattern. The poles must be isolated from any sur-
rounding magnetic material. Therefore, to maintain registration of these “floating”
poles relative to the flats, we bond the 0.004′′-thick foil (Magnetic Shield Corporation,
Bensenville IL) to a sacrificial sheet of 0.005′′-thick polycarbonate backing (K-mac Plas-
tics, Wyoming MI). Here I report on an array of pole flats (see the inset of Figure 5.11,
step 2), but any shape of pole tip may be specified at this stage. The pole plate pattern
is etched from the metal side of the foil-on-plastic.
To transfer the patterned foil to an optically clear substrate while maintaining
the registration of the poles, we roll UV-curable adhesive NOA 81 (Norland Optical
Adhesives, Cranburg NJ) onto the etched foil, cover it with #1-thickness coverglass,
press flat with a glass plate and cure, then remove the plastic backing. This orientation
places the sharp tip edge ∼ 100µm above the surface of the coverslip. A layer of
parylene, vapor-deposited at this stage, inhibits pole degradation.
The highest force is in the plane of the pole edge, where the force ranges as high
as ∼ 1nN (see Figure 5.12) on a 4.5µm bead. This geometry is desirable for some
applications, including rheometry of biomaterials. For other applications, including
cell force experiments, it is desirable to have the bottom of the well level with the pole.
To raise the cells to this height, we pot the foil in NOA 81, creating an optically clear
surface within 10µm of the plane of the poles. To create a surface conducive to cell
adhesion, we vapor-deposit 3-Aminopropyltriethoxysilane (Sigma-Aldrich, St. Louis
MO) solution onto the layer of NOA 81.
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Figure 5.12: A contour plot of force on a 4.5µm bead, overlayed on a time-
lapse image of a force calibration video. The contour step is 200pN . The pole
tip (bottom left) is attracting beads from the surrounding solution, which are
apparent as streaks in the timelapse image. Each contour line is the average
force measured on all beads at that distance from the pole tip, within 30◦ of the
pole’s axis of symmetry.
In the final step, five-minute epoxy bonds the potted pole plate to the 384-well
superstructure such that the wells will not leak. The result is a 384-well microplate
where three-quarters of the wells are used for the drive cores and ears, leaving 96 wells
for specimens.
5.3.2 MHTS Calibration
I have used Variable Force Calibration (VFC) (Cribb, 2010) to characterize the
forces in the MHTS6. Of greatest interest are the maximum force and crosstalk force.
Figure 5.14 demonstrates that the maximum forces are ∼ 1nN , and with 15 wells on
and one well off, the crosstalk is 3± 1%.
6I am indebted to David Bober for his work collecting this force calibration data.
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(a) (b)
Figure 5.13: The fully assembled MHTS prototype. (a) Seen from below, the
magnetics block drops into the 384 well microplate from above, and the pole plate
creates the bottom of the specimen wells. (b) In operation, tubing provides fluid
flow for temperature control, and a condenser objective provides transmission
brightfield illumination from above. The imaging objective is below, obscured by
the microplate.
Figure 5.14: A representative calibration set for maximum force (top curve) and
a calibration set showing crosstalk force (bottom curve) for a single well in the
MHTS. The insets show the drive current configuration for each curve. For the
maximum force calibration, the magnet in the active well is on and the other
fifteen are off; for the crosstalk measurement, the active well’s magnet is off and
the other fifteen are on.
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Ideally, the pole tips would be uniform from well to well, ensuring identical force
fields in all wells. However, the etching process that produces the pole plate pattern has
not proven reliable in producing uniformly sized poles, and therefore the calibration
varies from well to well by ±40%, as shown in Figure 5.15. If this uncertainty is
tolerable for the application, then a single calibration may be applied to data collected
in all wells. This situation may be tolerable particularly in circumstances where relative
measurements are of interest—for example, of sample closer to the pole tip versus
sample farther away, or the sample before and after the well is dosed with something
that might alter its mechanical properties. In specific mechanical experiments, the
material property may be independent of the applied stress—for example, the relaxation
time of a linear viscoelastic material. If greater accuracy is desired, each well can be
calibrated individually, resulting in a variation of ±10%.
Calibration of a single well typically takes three minutes for data acquisition, 15
minutes for particle tracking, and 20 minutes for data analysis.
5.3.3 MHTS Application: Cell Mechanics
There is potential for a high throughput force system to have a dramatic impact
on studies in cell mechanics and motility. A recent trend in biological studies has been
the development of libraries of small molecules, proteins and RNAi for gene expres-
sion manipulation. It was a motivation for our development of the MHTS technology
to explore gene expression-inhibited and ligand-mediated cell mechanical responses of
Drosophila (fruit fly) cell systems using a previously developed RNAi library (Rogers
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Figure 5.15: F(r) averaged over 15 wells in an MHTS magnetic microplate. One
calibration set was collected at maximum drive current in each well (d = 1).
The forces in each well are uniform to within ±40%, which is adequate for some
applications, including order-of-magnitude rheometry experiments.
and Rogers, 2008). Understanding these pathways will help reveal the genetic origins
of diseases such as cancer, hypertension and inflammatory disorders.
We have used the MHTS to study the mechanical response of cells under varying
biochemistry. Drosophila derived cells (SR2+) were grown in SF 900 medium on potted,
APTES treated, and Conconavalin A-washed magnetic microplates7. That cell cultures
grow in a magnetic microplate demonstrates MHTS biocompatibility; a representative
well is shown in Figure 5.16. Half of the wells with cells in them were treated with
a Protein Tyrosine Phosphatase (PTPase) inhibitor cocktail (Calbiochem, San Diego
CA), final concentration 0.5µM . Tyrosine Phosphatases have been known to play an
important role in force sensing in cells (Giannone and Sheetz, 2006), but there have
7I am indebted to David Bober, Vinay Swaminathan, and E. Timothy O’Brien, who all contributed
to this experiment. The text in this section is based on writing by V. Swaminathan.
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been no quantitative studies on the changes in the mechanical properties of the cell due
to the inhibition of PTPases.













Figure 5.16: Left: The magnetic microplate is compatible with cell cultures. The
shadow of the pole tip is visible, bottom left. Shown is a brightfield transmission
image of the Drosophila cells in the multiwell plate, 60x, 1.2 NA water immer-
sion objective. Magnetic beads (d = 2.8µm) are observed on the cells and their
trajectory is tracked using the CISMM Video Spot tracker software. Right: Com-
pliance J(t) = 3pidr(t)F (r,I) of individual Drosophila cells under control (dotted curves)
and PTPase inhibited conditions (solid curves). Each curve represents a single
bead on a single cell averaged over two pulls. All four beads were on cells in
separate wells. The forces acting on the beads ranges from 250 – 350pN .
Figure 5.16 also compares the compliance of treated and untreated cells, as measured
from bead displacements. The spring constant for a cell was found in a manner similar
to that used in Chapter 4. The spring constant for untreated drosophila cells was
756±67×10−6N/m. SR2+ cells which were treated with the PTPase inhibitor showed
greater compliance. The spring constant for cells treated with the PTPase inhibitor
was found to be 240± 53× 10−6N/m.
Using the MHTS technology, a single experiment enabled mechanical measurements
on cells in four independent cell cultures. The PTPase-treated SR2+ Drosophila cells
exhibited thrice the compliance of control conditions; this difference is outside the
uncertainty in the calibration of each well. Studies using the MHTS to study cell
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mechanoresponse under varying biochemical conditions are ongoing.
5.3.4 MHTS Application: Mucus Viscometry
The MHTS is the first technology for rheometry that we know to be high-throughput
compatible. As an example of its use as a microrheometer, I have used the MHTS to
measure rheology of mucus8 (Cribb, 2010).
Broadly defined, mucus refers to a family of soft, viscoelastic materials secreted at
the cellular and tissue scales by a wide variety of organisms, vertebrates and inverte-
brates alike. Its persistence through the evolutionary record speaks to its success in
coating, protecting, and/or lubricating cells and cell surfaces often found at interfaces
with epithelial cells (Desseyn et al., 2000). In the airways, mucus serves as the first
line of defense against the inhalation of pollutants or pathogens during breathing. In
pathologies such as cystic fibrosis, changes in mucus rheology can have a catastrophic
effect on muco-cilliary clearance.
Figure 5.17 demonstrates that the MHTS can be used to measure mucus viscosity.
In particular, the data demonstrate that driven microrheology can see shear-thinning
of a polymer system, and can capture bulk viscosity of the material in a manner that
single particle diffusion cannot.
8I operated the MHTS to collect the data of this Section. I am indebted to J. Cribb for his work
analyzing and publishing these data, and the text in this Section is based on his work.
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Figure 5.17: Left: Shear thinning response curve for 4% PGM measured with
cone-and-plate (CAP) (solid line). The steady state viscosity values as measured
by MHTS (scatter) originate from three different specimens tested by three dif-
ferent calibrated pole tips. All wells report viscosities similar to one another,
implying the spread in the data is due to sample heterogeneity. Right: Shear
thinning response curve for two specimens of HBE mucus measured with CAP
(solid lines). Diffusive measurements (squares) for 2.5% mucus are lower than the
CAP data by about 50%. However, MHTS measurements (triangles) for 5.3%
mucus agree with CAP and exhibit shear thinning, with error in each measure-
ment being <15%.
5.4 Governing Equations for MHTS Operation
To expand on this previously published work, I examine below three operation
modes for the MHTS: calibration, a shear thinning measurement, and a strain hardening
measurement. I derive the governing equations for what drive parameters and bead
sizes should be used to resolve desired material properties. The section on calibration
planning also highlights the data storage challenge created by the MHTS.
5.4.1 Calibration planning
In the interest of developing a smoothly operating MHTS, I propose a method to
programmatically plan a calibration.
Forces are calculated from the velocity of beads pulled through a fluid of known
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viscosity. For Newtonian fluids with a low Reynolds number (Re < 10−4), the force on
a spherical object is equal to the Stokes drag multiplied by the particle’s velocity,
F = 3pidηv, (5.1)
where d is the sphere diameter, η is the dynamic viscosity of the fluid, and v is the
sphere’s velocity. Given fluid viscosity and the bead radius, the bead’s velocity uniquely
determines the force at a given position and drive current. Calibration is typically
performed using 2.5M sucrose (η = 0.12Pa s). Corn syrup (ACH Food Companies,
Memphis TN), a higher viscosity fluid (η = 3.4Pa s, verified using CAP), can be used
to calibrate higher force regimes.
The inputs from the user are the vector of drive currents I and the fields of view to
be calibrated9. The new work presented below can be summarized as determining the
vector of dwell times tFOV and the number of times to repeat the pulse sequence pFOV
in each field of view.
Step 1: Find the coordinate system origin r(x0, y0) = 0. The force on a bead is a
function of distance from the pole tip, r. Within a 30◦ cone of the pole tip there is
little azimuthal variation in the force, and it can be assumed to be dependent only on
the radial coordinate r. In this step, image analysis algorithms would determine the
location of the pole tip, define the origin of this coordinate system, and translate all
bead positions into this coordinate system. These algorithms are under development,
9For a thorough calibration, I = [0, 0.1, 0.25, 0.5, 0.75, 1, 1.5, 2, 2.5] is typical.
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and are outside the scope of the present work.
The step will offer a major advantage over the current system. If the data are
collected in a location known relative to r = 0, then calibration and experiment data
may be collected in fields of view that do not include the pole tip. This dramatically
relaxes the field of view constraint for the multiscope, permitting higher magnification
without sacrificing force range, bead sparseness, and distance from boundaries (namely,
the pole tip). The remainder of this discussion will assume the need to calibrate multiple
fields of view.
Step 2: Determine the dwell time vector in each field of view, tFOV. It is critical
that ti, the dwell time at each drive current, be optimized. For dwell times that are too
short, the bead will not move far enough to make a measurement; for dwell times that
are too long, the bead will move too far, reducing the spacial resolution of calibration.
The proper t depends on how fast the bead moves, as determined by Equation 5.1.
This velocity cannot be known without knowing the force that that the pole tip
applies—precisely the quantity that calibration is used to determine. Thus we must





where α′I , and β
′
I are predicted fitting parameters at each drive current I. To calibrate
each field of view, it is sufficient to use the position of the center of the field relative to
the pole tip, rFOV. In the following calculation I will refer to the average force predicted
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at a particular current, for a particular bead, in a given field of view, < F′I(rFOV) >.
The following constraints exist on any given dwell time, ti. First, it must be more
than ten frames long for a good velocity measurement (the slope of a linear fit to r(t)).
Second, the bead must move ten times the imaging resolution ∆xmin. Third, the bead
must move more than ten times the root-mean-squared distance expected from thermal
diffusion. The third condition may be expressed as
∆r = vti =









where rD is the position of the bead due to diffusion, and kBT is the thermal energy.
After solving for ti above, the constraints on the dwell times may be summarized:
ti ≥ 10 tframe
ti ≥ 10 3piηd∆xmin
< F′I(rFOV) >




For spacial resolution and calibration speed, ti should be as small as possible. Thus, ti
will equal the largest of the three constraints. (In the zero-current case, F→ 0, and ti
can be taken as twice the the longest time for the non-zero current cases. These must
be calculated for each drive current I and each field of view rFOV to generate tFOV
Step 3: Determine the number of current pulses per field of view, pFOV. The pulse
sequence, consisting of the drive currents I applied for dwell times t, must be repeated
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at least enough times that a bead at one edge of the field of view be pulled. Namely,
∆r ≥ lframe (5.4)
where lframe is the real-space length of the frame’s diagonal. Each pulse sequence has a













where < F′I(rFOV) > is the vector of estimated average forces at the currents I for each
field of view. The average force, substituted explicitly in the far right term above, was




f . The total motion over a pulse
sequence is therefore
∆rFOV = pFOV(vFOV · tFOV), (5.6)
where pFOV is the number of pulse sequence repeats for a given field of view, and is
solved for by combining Equations 5.4, 5.5 and 5.6:
pFOV ≥ lFOV 3piηd
< F′I(rFOV) > · tFOV
(5.7)
The calibration plan developed in steps 2 and 3 is summarized in Figure 5.18. Note
that as the forces get smaller, whether by reducing the drive current or moving farther
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from the pole tip, the time required to apply the force increases. The number of pulse
sequences in each field of view peaks at the intermediate distances from the pole tip,
where the imaging resolution ∆xmin determines most ti. Farther away from the pole
tip, diffusion interferes with the force measurement, requiring longer-distance pulls, and
therefore reducing the number of pulse sequences per field of view.
Figure 5.18: Plan for a single well calibration. Pulse times ti get longer as the
forces get smaller (upper-right corner of table). A full well calibration takes
∼ 100GB, about 70GB of which is collected when calibrating the final two fields
of view.
Step 4: Calibrate. In this step, the pulse sequences run in each field of view. The
first field of view should be the one closest to the pole tip, where beads are depleted
most rapidly. Subsequent fields of view may be observed, moving progressively away
from the pole tip, until data have been collected over the full range of r. Software must
be developed to track the beads and convert their position data into the coordinate
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system of the pole tip. The data analysis then proceeds as in the existing variable force
calibration.
Step 5: Verify t and re-calibrate if necessary. Because the preceding steps use a
predicted calibration for the drive magnet planning, there is the possibility that the
collected data will not meet the constraints 5.3. The easiest solution is to check each












are met, then the datum should be excluded from the calibration as it will distort the
fit to the calibration data. If the amount of excluded data is great enough to cause
concern, the output of the analysis—a new family of force equations FI(r)—may be
used in Equation 5.2 to repeat the calibration planning, generating a more satisfactory
vector of dwell times t.
It is critical that the plate calibration is consistent from run to run. Harm to the
pole tip is the most common way to change a well’s calibration, whether by chipping,
bending, or rusting. All three manifest in direct imaging of the pole tip; therefore, it
is advisable to record an image of the pole tip shape on each experimental run, for
comparison to the image of the tip during calibration.
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5.4.2 Planning strain stiffening measurements
Similar attention is merited for the planning of strain stiffening measurements. Here,








where ∆x is the recovery displacement of the bead and G is the storage modulus of the
material. For a microbead, we take γ = ∆x/d.
Substituting γ for Equation 5.11, solving for F, and using a prediction of the strain
stiffening equation G′(γ)10, we find
F = 3pid2γG′(γ). (5.12)
As with the shear thinning case, this can be plotted to determine which beads should
be used to obtain which forces. However, there is a second constraint, imposed by the
optical system, analogous to Equation 5.14 from the shear thinning experiment. When
probing viscous (velocity dependent) properties, the signal-to-noise ratio will improve
by pulling longer; not so with elastic (displacement dependent) properties. For any
given bead, the measurement is limited at γmin = ∆xmin/d. A planning plot for a
10The prediction of the nonlinear storage modulus G′(γ) should not be confused with G′(ω), which
is the real part of the complex modulus G∗(ω), and is defined only in the material’s linear regime.
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strain stiffening experiment on a theoretical specimen, shown in Figure 5.19, reveals
how larger beads are required to make measurements at lower strains.
I should note that the particle size issue here adds to the particle size constraints
discussed in Chapter 4. Here, all particles are assumed to be big enough that they
measure bulk elastic properties. In addition, Figure 5.19 shows that in order to measure
a wide range of strains, additional constraints are placed on the particle size—namely,
because of the nature of the strain equation γ = ∆x/d, the particles must be bigger.
Figure 5.19: A planning plot for a strain stiffening experiment. The predicted
G′(γ) is taken from a real measurement of fibrin elasticity, the 1 mg/mL specimen in
Figure 4.4. The plots for each bead truncate at the left due to the measurement
constraint ∆xmin, taken here to be 1 µm.
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5.4.3 Planning shear thinning measurements
The stress geometry of the MHTS is best expressed in polar coordinates. This is not
the natural system for viscometry experiments, and as such, the experimental design
is critical to achieving a successful measurement. Prior work (Cribb, 2010) has noted
that the force required to see a given shear rate is
F = pi γ˙ d2 η′(γ˙). (5.13)
where γ˙ is the shear rate, and η′(γ˙) is the predicted shear thinning curve.
To this I add a prescription for determining the time that force should be applied,
∆t. The imaging resolution, ∆xmin, sets one constraint, which paired with the minimum









A good rule of thumb sets ∆xmin = d. I also note we wish to avoid any force strong
enough that ∆t < tframe. Without this latter condition, the bead may move more
than its diameter in a single frame, making it difficult to track.
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5.5 High Throughput Data Collection
With the experimental systems, MHTS and Panoptes, well-envisioned, and with
the analysis pipeline well defined, the pieces are in place to begin designing the user
environment for high throughput data collection.
A workflow for preparing experiments is shown in Figure 5.20. As with the data
analysis workflow, the steps that involve feedback are critical to creating an effective
solution. In particular, I highlight the need to fine-tune the imaging parameters, and to
“double-check” the metadata. The former is key to ensuring good data quality, and the
latter is key to avoiding disastrous book-keeping confusion. Because we have limited
experience automatically collecting large volumes of data, I will defer on proposing
a complete interface for the experimental UI. The layout and functionality of this
environment should remain an active area of discussion as this system’s development
continues.
5.6 Conclusions
It is an overarching goal of our research group to develop a high throughput sys-
tem that supports preparation of multiple specimens in industry standard microplates,
measure diffusion in and apply forces to particles added to those specimens, and track
the motion of the particles as efficiently as possible. In this chapter I have documented
the challenges facing high throughput passive and driven microrheology, and detailed
system designs that address many of the issues.
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Figure 5.20: Workflow for taking high throughput MHTS data.
This development effort may be summarized as a collection of subsystems with spe-
cific functionality, summarized in Figure 5.21. It also summarizes how the functionality
of the various subsystems is encapsulated in various development projects, namely the
MHTS, Panoptes, the experimental UI, and DataBrowser.
While supersystem considerations are the least critical for creating a functioning
instrument, they are the most critical for creating a usable one. I am indebted to
the work of previous students (Cribb, 2010), especially with regard to physical layout,
metadata handling, and methods for synchronizing video and magnet logs. Yet the
existing system remains difficult to comprehend, laborious to operate, and easy to
misuse. New users still have great difficulty learning to plan experiments and keeping
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Figure 5.21: Systems overview of the MHTS. The functionality can be broken
into six projects (grey boxes), while the user experiences four modular products:
experimental UI, DataBrowser, MHTS, and Panoptes.
track of files generated by data collection. The former consideration was the motivation
behind the experimental planning sections of this chapter; the latter was the motivation




Experimental Protocols for Diffusion,
Structure, and Permeability
A.1 Clot preparation and Video Acquisition
Reagent handling, storage, thawing, and mixing. Particle concentrations were
planned to obtain sufficient number density n < 10−4µm−3 (φ < 7× 10−6).
Clots were formed in a glass-bottom 96-well microplate (NUNC, Rochester NY),
which was plasma cleaned to ensure uniform clotting and meniscus in all wells. Clots
were allowed to incubate for two hours, which was the time before the level section of
the slowest turbidity curve. For experiments where the particles diffused into the clot
from outside, particles were added after this two hour incubation. Clots were sealed to
prevent evaporation and diffusion proceeded at room temperature.
Video of nanoparticle diffusion was acquired on a inverted microscope (Nikon USA,
Melville NY) with a 60x, 1.2 NA water immersion objective (Olympus, Center Valley
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PA), and a high-sensitivity EMCCD camera (Photometrics, Tucson AZ). Videos were
captured in at least five well-distributed fields of view, at a constant height of 50-70 µm
from the glass substrate, at rates of 24-31 frames per second, for at least 60 seconds.
A.2 Automatic particle tracking and data filtering
Particles were automatically tracked using CISMM Video Spot Tracker. Some false
positive particle tracks were inevitable; data were filtered to eliminate any tracks lasting
less than two seconds. There is a risk of biasing diffusion results by filtering in this
fashion, as it could asymmetrically trim the natural diffusion distribution. However,
a track of a real particle can be expected to last for the first passage time across
the imaging system’s depth of field of about 5 µm. For the smallest particles used
the average expected residence time in buffer is 3.4 seconds. After this filtering, the
greatest damage to data fidelity were due to trackers that lost a particle but continued
to log data. These “pop-offs” were pruned by hand in several datasets, and resulted in
corrections to Deff of under 5%.
A.3 Calculation of diffusion coefficient
Calculated 〈r2〉 from tracking data (x(t), y(t)). Calculated α by linear fit to 〈r2〉
over the range 0.1 < τ < 1. Filtered by 0.8 < α < 1.2. Computed Deff = 〈r2〉/4τ for
each tracker. Computed mean and standard error for Deff for each clot type.
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A.4 PEG Particle Preparation
Carboxylate nanoparticles were functionalized as in (Lai et al., 2007). In an effort
to evaluate the sensitivity of our diffusion measurement, we compared the size of the
PEG- and COOH-functionalized particles. The presence of PEG at the surface of a
nanoparticle should increase its hydrodynamic size. Particle diameters were determined
by dynamic light scattering (DLS) (Malvern Instruments, Worcestershire UK) and from
particle diffusion in water. These data imply a corona around the particles that is 5 nm
(250 nm initial size) and 12 nm (490 nm initial size).
A.5 Structure and Permeability
Clotting time measured with turbidity. Gel structure was measured using confocal
microscopy of fluorescent fibrinogen. Alexa-fluor fibrinogen (AFF) was prepared by
Robert Campbell. Fibrin gels were prepared with plasma-purified fibrinogen doped
with 3% AFF. Stacks were acquired on an inverted microscope (Nikon USA, Melville
NY) with a 60x, 1.2 NA water immersion objective (Olympus, Center Valley PA),
a spinning disk, confocal fluorescence system (Yokogawa, Atlanta GA), and a CCD
camera (Photometrics, Tucson AZ). For each clot type, at least two stacks were taken
in different locations of the clot.
Clot permeability was measured for purified fibrin gels. Results agreed with estab-




Panoptes Bill of Materials
Component Manufacturer Model Cost
X-Y Translation stage LUDL BioPrecision2 $15,000
Imaging Objective UkaOptics 40X NA 0.65
Varioptic Lens Varioptic Arctic 416 $360
Varioptic Mount Custom
Filter set Omega XF102 $500
Fluorescence LED Phillips LumiLED Green $6
Epi-Fluoro Collector lens Edmunds $30
Camera Point Grey Flea2
Figure B.1: Bill of materials for chosen parts. Designs for some components have
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